syndrome	score	normalized_score
ASTHMA, NASAL POLYPS, AND ASPIRIN INTOLERANCE	1.0119048	100.0
108450 ASYMMETRIC SHORT STATURE SYNDROME	1.0	98.82352569134963
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	1.0	98.82352569134963
CHIARI MALFORMATION TYPE II	1.0	98.82352569134963
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.642857	63.52939525536395
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.5070922	50.112639054583006
RHYNS SYNDROME	0.5	49.411762845674815
CLUSTER HEADACHE, FAMILIAL	0.5	49.411762845674815
SPONDYLOEPIPHYSEAL DYSPLASIA, CANTU TYPE	0.5	49.411762845674815
NORMOSMIC CONGENITAL HYPOGONADOTROPIC HYPOGONADISM	0.5	49.411762845674815
8Q24.3 MICRODELETION SYNDROME	0.5	49.411762845674815
SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH	0.5	49.411762845674815
TRIGEMINAL NEURALGIA	0.5	49.411762845674815
PELVIS-SHOULDER DYSPLASIA	0.5	49.411762845674815
HEMIDYSTONIA-HEMIATROPHY SYNDROME	0.5	49.411762845674815
%271630 BRACHYOLMIA TYPE 1, TOLEDO TYPE;;SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, TOLEDO TYPE;;SED, CHONDROITIN SULFATE TYPE;;PAPS-CHONDROITIN SULFATE SULFOTRANSFERASE DEFICIENCY	0.3627448	35.84772006220348
PSEUDOACHONDROPLASIA	0.3522009	34.80573468966646
PITUITARY DERMOID AND EPIDERMOID CYSTS	0.35	34.588233991972366
ATELOSTEOGENESIS TYPE I	0.344322	34.027114013096885
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.333333	32.941142289274644
HYPOCHONDROPLASIA	0.333333	32.941142289274644
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL DOMINANT	0.333333	32.941142289274644
HYPOCHONDROPLASIA	0.333333	32.941142289274644
LETHAL KNIEST-LIKE DYSPLASIA	0.309524	30.588252966089303
KNIEST-LIKE DYSPLASIA, LETHAL	0.260989	25.791853146659648
THANATOPHORIC DYSPLASIA, TYPE I	0.2570922	25.406757631745595
THANATOPHORIC DYSPLASIA TYPE 1	0.25	24.705881422837408
PITUITARY DEFICIENCY DUE TO RATHKE CLEFT CYSTS	0.25	24.705881422837408
THANATOPHORIC DYSPLASIA, TYPE II	0.25	24.705881422837408
SHEEHAN SYNDROME	0.25	24.705881422837408
PITUITARY APOPLEXY	0.25	24.705881422837408
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE	0.210989	20.85067686209217
ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 2; FASPS2	0.20424822	20.18452921658243
CRI-DU-CHAT SYNDROME	0.20364964000000002	20.125375430574106
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.20364964000000002	20.125375430574106
TRANSALDOLASE DEFICIENCY	0.2	19.764705138269925
BENIGN SAMARITAN CONGENITAL MYOPATHY	0.2	19.764705138269925
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 5	0.19444430000000001	19.215671276586495
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1	0.19444430000000001	19.215671276586495
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 3	0.19444430000000001	19.215671276586495
MIGRAINE, FAMILIAL TYPICAL, SUSCEPTIBILITY TO, 2	0.19444430000000001	19.215671276586495
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 10	0.19444430000000001	19.215671276586495
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 11	0.19444430000000001	19.215671276586495
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 6	0.19444430000000001	19.215671276586495
%156230 MESOMELIC DWARFISM OF HYPOPLASTIC TIBIA AND RADIUS TYPE	0.1916667	18.9411790516262
LANGER MESOMELIC DYSPLASIA	0.1737592	17.17149676530836
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.17226879999999997	17.024210182617967
BOHRING-OPITZ SYNDROME	0.16731889	16.5350426245631
HEART DEFECTS-LIMB SHORTENING SYNDROME	0.166667	16.47062055640017
PALLISTER-KILLIAN SYNDROME	0.166667	16.47062055640017
BONE DYSPLASIA, LETHAL HOLMGREN TYPE	0.15384599999999998	15.203604133511373
GREENBERG DYSPLASIA	0.15384599999999998	15.203604133511373
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.14761499999999997	14.587834744928571
SPONDYLOCHEIRODYSPLASIA, EHLERS-DANLOS SYNDROME-LIKE	0.14350888999999997	14.182054477852066
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.14285699999999998	14.117632409689133
OMODYSPLASIA	0.14285699999999998	14.117632409689133
MICROCEPHALIC PRIMORDIAL DWARFISM-INSULIN RESISTANCE SYNDROME	0.14285699999999998	14.117632409689133
ACROMESOMELIC DYSPLASIA, HUNTER-THOMPSON TYPE	0.14285699999999998	14.117632409689133
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.14285699999999998	14.117632409689133
ATELOSTEOGENESIS TYPE II	0.14285699999999998	14.117632409689133
METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE	0.14285699999999998	14.117632409689133
SLC39A13-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.14285699999999998	14.117632409689133
RETINOPATHY, PIGMENTARY, AND MENTAL RETARDATION	0.14285699999999998	14.117632409689133
ACROMESOMELIC DYSPLASIA, HUNTER-THOMPSON TYPE	0.14285699999999998	14.117632409689133
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.14285699999999998	14.117632409689133
CLEIDOCRANIAL DYSPLASIA; CCD	0.14285699999999998	14.117632409689133
BOOMERANG DYSPLASIA	0.14285699999999998	14.117632409689133
BRACHYDACTYLY, TYPE E	0.14285699999999998	14.117632409689133
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE	0.14285699999999998	14.117632409689133
DYSCHONDROSTEOSIS AND NEPHRITIS	0.125	12.352940711418704
MESOMELIA-SYNOSTOSES SYNDROME	0.125	12.352940711418704
NIEVERGELT SYNDROME	0.125	12.352940711418704
ODONTOCHONDRODYSPLASIA; ODCD	0.125	12.352940711418704
MESOMELIC DYSPLASIA, NIEVERGELT TYPE	0.125	12.352940711418704
DYSCHONDROSTEOSIS-NEPHRITIS SYNDROME	0.125	12.352940711418704
BARATELA-SCOTT SYNDROME	0.1212454	11.981897901857963
DEAFNESS, SENSORINEURAL, WITH PITUITARY DWARFISM	0.11176288999999999	11.044802831254481
MIGRAINE WITHOUT AURA, SUSCEPTIBILITY TO, 4	0.11111099999999999	10.980380763091548
PANHYPOPITUITARISM	0.11111099999999999	10.980380763091548
PITUITARY DWARFISM WITH LARGE SELLA TURCICA	0.11111099999999999	10.980380763091548
PITUITARY DWARFISM WITH SMALL SELLA TURCICA	0.11111099999999999	10.980380763091548
PITUITARY DWARFISM IV	0.11111099999999999	10.980380763091548
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.11111099999999999	10.980380763091548
PANHYPOPITUITARISM, X-LINKED	0.11111099999999999	10.980380763091548
PAROXYSMAL HEMICRANIA	0.10980392	10.8512105091309
BEHÇET DISEASE	0.10980392	10.8512105091309
SHORT SYNDROME	0.10633490000000001	10.508389722037094
INTESTINAL LYMPHANGIECTASIA	0.10364964	10.24302286143914
ESOPHAGEAL ATRESIA	0.10364964	10.24302286143914
HENNEKAM-BEEMER SYNDROME	0.10065189000000001	9.946774637297898
HYPOTRICHOSIS WITH JUVENILE MACULAR DEGENERATION	0.10065189000000001	9.946774637297898
CARNEY COMPLEX	0.1	9.882352569134962
DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS	0.1	9.882352569134962
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.1	9.882352569134962
PARAGANGLIOMAS 4	0.1	9.882352569134962
PARAGANGLIOMAS 1	0.1	9.882352569134962
ACQUIRED ICHTHYOSIS	0.1	9.882352569134962
NON-FUNCTIONING PARAGANGLIOMA	0.1	9.882352569134962
SPORADIC PHEOCHROMOCYTOMA/SECRETING PARAGANGLIOMA	0.1	9.882352569134962
ARNOLD-CHIARI MALFORMATION TYPE I	0.1	9.882352569134962
PARAGANGLIOMAS 3	0.1	9.882352569134962
DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.1	9.882352569134962
HEREDITARY PHEOCHROMOCYTOMA-PARAGANGLIOMA	0.1	9.882352569134962
DRACUNCULIASIS	0.1	9.882352569134962
RHEUMATOID ARTHRITIS	0.0901315	8.907112605849878
PETERS-PLUS SYNDROME; PTRPLS	0.0879121	8.687783672930498
CAMPOMELIC DYSPLASIA	0.08553459999999999	8.452830740599312
MYHRE SYNDROME	0.08466719	8.367110226179381
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.08333330000000001	8.235290513494947
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.08333330000000001	8.235290513494947
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.08333330000000001	8.235290513494947
ACHONDROPLASIA	0.0776557	7.674210064029739
BLOMSTRAND LETHAL CHONDRODYSPLASIA	0.0776557	7.674210064029739
MEIER-GORLIN SYNDROME 1; MGORS1	0.07692310000000001	7.601811949108257
MEIER-GORLIN SYNDROME 2; MGORS2	0.07692310000000001	7.601811949108257
ULBRIGHT-HODES SYNDROME	0.07692310000000001	7.601811949108257
MEIER-GORLIN SYNDROME 3; MGORS3	0.07692310000000001	7.601811949108257
MEHMO SYNDROME; MEHMO	0.07692310000000001	7.601811949108257
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.07692310000000001	7.601811949108257
MEIER-GORLIN SYNDROME 5; MGORS5	0.07692310000000001	7.601811949108257
DYSSEGMENTAL DYSPLASIA, ROLLAND-DESBUQUOIS TYPE	0.07375889999999999	7.289114549115687
SLC35A2-CDG	0.07354199	7.2676787381579775
191400 ULNA AND FIBULA, HYPOPLASIA OF;;MESOMELIC DWARFISM OF HYPOPLASTIC ULNA AND FIBULA TYPE;;REINHARDT-PFEIFFER MESOMELIC DYSPLASIA	0.0666667	6.588238340207497
ELLIS VAN CREVELD SYNDROME	0.0666667	6.588238340207497
ELLIS-VAN CREVELD SYNDROME	0.0666667	6.588238340207497
CARTILAGE-HAIR HYPOPLASIA; CHH	0.0666667	6.588238340207497
DIASTROPHIC DWARFISM	0.0666667	6.588238340207497
250230 METAPHYSEAL CHONDRODYSPLASIA, KAITILA TYPE	0.062346200000000004	6.161271297458022
EPIPHYSEAL DYSPLASIA, MULTIPLE, 1	0.0592934	5.85958283822747
ACROCAPITOFEMORAL DYSPLASIA; ACFD	0.0573294	5.66549343376966
SPONDYLOMETAPHYSEAL DYSPLASIA, EAST AFRICAN TYPE	0.0573294	5.66549343376966
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0572414	5.65679696350882
MUCOPOLYSACCHARIDOSIS, TYPE II	0.0523303	5.171464746486034
NEUROFIBROMATOSIS TYPE 1	0.04950653000000001	4.892409839344572
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0466532	4.610433708783672
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0458128	4.527382417792662
ACHONDROGENESIS TYPE 1B	0.0455537	4.501777242286034
CRANIOPHARYNGIOMA	0.04537634	4.484249901769416
CHONDROITIN-6-SULFATURIA, DEFECTIVE CELLULAR IMMUNITY, NEPHROTIC SYNDROME	0.04413019000000001	4.361100965229141
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.04413019000000001	4.361100965229141
AUTOSOMAL DOMINANT HYPOPHOSPHATEMIC RICKETS	0.04413019000000001	4.361100965229141
NEONATAL LUPUS ERYTHEMATOSUS	0.043478300000000004	4.296678897066207
MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS,AND HYPOSEGMENTED LUNGS	0.043478300000000004	4.296678897066207
178610 PULMONARY NODULAR LYMPHOID HYPERPLASIA, FAMILIAL	0.043478300000000004	4.296678897066207
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J	0.043478300000000004	4.296678897066207
HYPOPLASMINOGENEMIA	0.043478300000000004	4.296678897066207
LICHTENSTEIN SYNDROME	0.043478300000000004	4.296678897066207
JUVENILE XANTHOGRANULOMA	0.043478300000000004	4.296678897066207
HYDROXYKYNURENINURIA	0.043478300000000004	4.296678897066207
WHITE FORELOCK WITH MALFORMATIONS	0.043478300000000004	4.296678897066207
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.043478300000000004	4.296678897066207
FASCIAL DYSTROPHY, CONGENITAL	0.043478300000000004	4.296678897066207
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.043478300000000004	4.296678897066207
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.043478300000000004	4.296678897066207
HEMOSIDEROSIS, PULMONARY, WITH DEFICIENCY OF GAMMA-A GLOBULIN	0.043478300000000004	4.296678897066207
PSEUDOTRISOMY 13 SYNDROME	0.043478300000000004	4.296678897066207
WEILL-MARCHESANI SYNDROME 1; WMS1	0.04065189	4.017363095816919
12Q14 MICRODELETION SYNDROME	0.04065189	4.017363095816919
KNIEST DYSPLASIA	0.0404008	3.992549496751078
CHST3-RELATED SKELETAL DYSPLASIA	0.0404008	3.992549496751078
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.04	3.9529410276539854
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.04	3.9529410276539854
WEILL-MARCHESANI SYNDROME 2; WMS2	0.04	3.9529410276539854
PLACENTAL INSUFFICIENCY	0.04	3.9529410276539854
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.04	3.9529410276539854
SPONDYLOEPIPHYSEAL DYSPLASIA, KIMBERLEY TYPE	0.04	3.9529410276539854
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.04	3.9529410276539854
TRANSKETOLASE DEFICIENCY	0.04	3.9529410276539854
HALLERMANN-STREIFF SYNDROME	0.04	3.9529410276539854
SHORT STATURE AND FACIOAURICULOTHORACIC MALFORMATIONS	0.04	3.9529410276539854
CENTRAL PRECOCIOUS PUBERTY	0.04	3.9529410276539854
SECKEL SYNDROME 1; SCKL1	0.04	3.9529410276539854
HALLERMANN-STREIFF SYNDROME; HSS	0.04	3.9529410276539854
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.04	3.9529410276539854
DERMOTRICHIC SYNDROME	0.04	3.9529410276539854
SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS	0.04	3.9529410276539854
SHORT STATURE WITH NONSPECIFIC SKELETAL ABNORMALITIES	0.04	3.9529410276539854
SPONDYLOEPIPHYSEAL DYSPLASIA, KIMBERLEY TYPE	0.04	3.9529410276539854
DUANE ANOMALY-MYOPATHY-SCOLIOSIS SYNDROME	0.04	3.9529410276539854
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.04	3.9529410276539854
DISPROPORTIONATE SHORT STATURE WITH PTOSIS AND VALVULAR HEART LESIONS	0.039113390000000005	3.865323101540778
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.0384615	3.8009010333778437
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.0384615	3.8009010333778437
KYPHOMELIC DYSPLASIA	0.0384615	3.8009010333778437
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE; SEMDSH	0.0384615	3.8009010333778437
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.0384615	3.8009010333778437
SPONDYLOMEGAEPIPHYSEAL DYSPLASIA WITH UPPER LIMB MESOMELIA, PUNCTATECALCIFICATIONS, AND DEAFNESS	0.0384615	3.8009010333778437
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.0384615	3.8009010333778437
ACROMESOMELIC DYSPLASIA, MAROTEAUX TYPE	0.0384615	3.8009010333778437
KYPHOMELIC DYSPLASIA	0.0384615	3.8009010333778437
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.0384615	3.8009010333778437
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.0384615	3.8009010333778437
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.0384615	3.8009010333778437
MESOMELIC DWARFISM, REINHARDT-PFEIFFER TYPE	0.0384615	3.8009010333778437
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.0384615	3.8009010333778437
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA	0.0384615	3.8009010333778437
PHOCOMELIA, SCHINZEL TYPE	0.0384615	3.8009010333778437
SPONDYLOEPIMETAPHYSEAL DYSPLASIA CONGENITA, STRUDWICK TYPE	0.0384615	3.8009010333778437
DYSOSTEOSCLEROSIS	0.0384615	3.8009010333778437
SHORT STATURE-VALVULAR HEART DISEASE-CHARACTERISTIC FACIES SYNDROME	0.0384615	3.8009010333778437
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.0384615	3.8009010333778437
NORRIE DISEASE	0.038375320000000004	3.7923844219337637
SPONDYLOCOSTAL DYSOSTOSIS, AUTOSOMAL RECESSIVE 1	0.036503999999999995	3.6074539818370264
SPONDYLOCOSTAL DYSOSTOSIS 5	0.036503999999999995	3.6074539818370264
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.03480392	3.439446082279677
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.033985190000000005	3.358536297090399
AARSKOG-SCOTT SYNDROME	0.033985190000000005	3.358536297090399
WIDOW'S PEAK SYNDROME	0.033985190000000005	3.358536297090399
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.0333333	3.2941142289274645
DIGITOTALAR DYSMORPHISM	0.0333333	3.2941142289274645
ACROFACIAL DYSOSTOSIS, WEYERS TYPE	0.0333333	3.2941142289274645
BRACHYOLMIA	0.0333333	3.2941142289274645
EPIPHYSEAL DYSPLASIA, MULTIPLE, 7; EDM7	0.0333333	3.2941142289274645
WEYERS ACROFACIAL DYSOSTOSIS	0.0333333	3.2941142289274645
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.0333333	3.2941142289274645
BRACHYDACTYLY, MONONEN TYPE	0.0333333	3.2941142289274645
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.0333333	3.2941142289274645
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.0333333	3.2941142289274645
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.0333333	3.2941142289274645
EPIPHYSEAL DYSPLASIA, MULTIPLE, 2; EDM2	0.0333333	3.2941142289274645
SPONDYLOMETAPHYSEAL DYSPLASIA, 'CORNER FRACTURE' TYPE	0.0333333	3.2941142289274645
OSTEOCHONDRODYSPLASIA, BRACHYDACTYLY, AND OVERLAPPING MALFORMED DIGITS; OCBMD	0.0333333	3.2941142289274645
SPARSE HAIR-SHORT STATURE-SKIN ANOMALIES SYNDROME	0.0333333	3.2941142289274645
EPIPHYSEAL DYSPLASIA, MULTIPLE, 3; EDM3	0.0333333	3.2941142289274645
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.0333333	3.2941142289274645
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.0333333	3.2941142289274645
PELGER-HUET ANOMALY; PHA	0.0333333	3.2941142289274645
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 1	0.0333333	3.2941142289274645
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.0333333	3.2941142289274645
601450 DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM;;HIP, CONGENITAL DISLOCATION OF, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM	0.0333333	3.2941142289274645
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.03306144	3.267248065233014
22Q11.2 MICRODUPLICATION SYNDROME	0.03222104	3.184196774242004
TRICHOHEPATOENTERIC SYNDROME 1	0.030063689999999997	2.970999841091771
NAVAJO NEUROHEPATOPATHY	0.030063689999999997	2.970999841091771
SMITH-MAGENIS SYNDROME; SMS	0.030063689999999997	2.970999841091771
OPSISMODYSPLASIA; OPSMD	0.0298569	2.950564124214057
OMODYSPLASIA 1; OMOD1	0.0298569	2.950564124214057
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.0294118	2.906577772928837
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.0294118	2.906577772928837
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.0294118	2.906577772928837
ECHO VIRUS 11 SENSITIVITY	0.0294118	2.906577772928837
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.0294118	2.906577772928837
SPONDYLOCOSTAL DYSOSTOSIS 2, AUTOSOMAL RECESSIVE; SCDO2	0.0294118	2.906577772928837
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, IRAPA TYPE	0.0294118	2.906577772928837
MUCOPOLYSACCHARIDOSIS TYPE 6	0.0294118	2.906577772928837
%271530 BRACHYOLMIA TYPE 1, HOBAEK TYPE;;BRACHYOLMIA, RECESSIVE TYPE OF HOBAEK;;SPONDYLODYSPLASIA WITH PURE BRACHYOLMIA	0.0294118	2.906577772928837
DIAPHANOSPONDYLODYSOSTOSIS	0.0294118	2.906577772928837
SCHISTOSOMA MANSONI INFECTION, SUSCEPTIBILITY/RESISTANCE TO	0.0294118	2.906577772928837
ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	0.0294118	2.906577772928837
DEFECTIVE INTERFERING PARTICLE INDUCTION, CONTROL OF	0.0294118	2.906577772928837
IMMUNE SUPPRESSION	0.0294118	2.906577772928837
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.0294118	2.906577772928837
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.0294118	2.906577772928837
RAGWEED SENSITIVITY	0.0294118	2.906577772928837
RADIATION SENSITIVITY OF NATURAL KILLER ACTIVITY	0.0294118	2.906577772928837
RHEUMATIC FEVER-RELATED ANTIGENRHEUMATIC FEVER, ACUTE, SUSCEPTIBILITY TO, INCLUDED	0.0294118	2.906577772928837
SCHIMKE IMMUNO-OSSEOUS DYSPLASIA	0.0294118	2.906577772928837
MYELOPEROXIDASE DEFICIENCY	0.0294118	2.906577772928837
AMYLOIDOSIS	0.0294118	2.906577772928837
MONOMELIC AMYOTROPHY	0.0294118	2.906577772928837
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.0294118	2.906577772928837
BLOOD GROUP, DUFFY SYSTEM; FY	0.0294118	2.906577772928837
SUSCEPTIBILITY TO LYSIS BY ALLOREACTIVE NATURAL KILLER CELLS	0.0294118	2.906577772928837
SPONDYLOCOSTAL DYSOSTOSIS-ANAL ATRESIA-GENITOURINARY MALFORMATION SYNDROME	0.0294118	2.906577772928837
ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS	0.0294118	2.906577772928837
MYASTHENIA GRAVIS; MG	0.0294118	2.906577772928837
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.0294118	2.906577772928837
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.0294118	2.906577772928837
MORQUIO SYNDROME A	0.0294118	2.906577772928837
SPONDYLO-MEGAEPIPHYSEAL-METAPHYSEAL DYSPLASIA; SMMD	0.0294118	2.906577772928837
IMMUNOGLOBULIN D LEVEL IN PLASMA, LOW	0.0294118	2.906577772928837
GLOBULIN ANOMALY INVOLVING BETA (2A)-GLOBULIN	0.0294118	2.906577772928837
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.0294118	2.906577772928837
SPONDYLOCOSTAL DYSOSTOSIS-HYPOSPADIAS-INTELLECTUAL DISABILITY SYNDROME	0.0294118	2.906577772928837
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, KOHN TYPE	0.0294118	2.906577772928837
INOSINE PHOSPHORYLASE DEFICIENCY, IMMUNE DEFECT DUE TO	0.0294118	2.906577772928837
300106 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED;;SEMD, X-LINKED; SEMDX	0.0294118	2.906577772928837
SMITH-MCCORT DYSPLASIA 2; SMC2	0.0294118	2.906577772928837
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL RECESSIVE, LEROY-SPRANGERTYPE	0.0294118	2.906577772928837
SPONDYLO-OCULAR SYNDROME	0.0294118	2.906577772928837
SCHWARTZ-JAMPEL SYNDROME	0.02922329	2.8879485501007607
INTELLECTUAL DISABILITY-POLYDACTYLY-UNCOMBABLE HAIR SYNDROME	0.02922329	2.8879485501007607
C SYNDROME	0.02922329	2.8879485501007607
PENTASOMY X	0.02922329	2.8879485501007607
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.02922329	2.8879485501007607
FETAL ALCOHOL SYNDROME	0.02922329	2.8879485501007607
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.02922329	2.8879485501007607
ACRODYSOSTOSIS	0.02922329	2.8879485501007607
GALLOWAY-MOWAT SYNDROME	0.02922329	2.8879485501007607
SHORT STATURE-DEAFNESS-NEUTROPHIL DYSFUNCTION-DYSMORPHISM SYNDROME	0.02922329	2.8879485501007607
CHARGE SYNDROME	0.02922329	2.8879485501007607
DISTAL MONOSOMY 7Q36	0.02922329	2.8879485501007607
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.02922329	2.8879485501007607
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.02922329	2.8879485501007607
COFS SYNDROME	0.02922329	2.8879485501007607
HAIR DEFECT-PHOTOSENSITIVITY-INTELLECTUAL DISABILITY SYNDROME	0.0285714	2.8235264819378267
CONGENITAL DISORDER OF GLYCOSYLATION	0.0285714	2.8235264819378267
DOWN SYNDROME	0.0285714	2.8235264819378267
TRIOSE PHOSPHATE-ISOMERASE DEFICIENCY	0.0285714	2.8235264819378267
TETRASOMY X	0.0285714	2.8235264819378267
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.0285714	2.8235264819378267
NEUTROPENIA-MONOCYTOPENIA-DEAFNESS SYNDROME	0.0285714	2.8235264819378267
GHOSAL HEMATODIAPHYSEAL DYSPLASIA	0.0285714	2.8235264819378267
CHEILITIS GLANDULARIS	0.0285714	2.8235264819378267
CONGENITAL LOBAR EMPHYSEMA	0.0285714	2.8235264819378267
SOTOS SYNDROME	0.0285714	2.8235264819378267
ALPHA-THALASSEMIA	0.0285714	2.8235264819378267
ALG12-CDG	0.0285714	2.8235264819378267
COG7-CDG	0.0285714	2.8235264819378267
ALG1-CDG	0.0285714	2.8235264819378267
MENDELIAN SUSCEPTIBILITY TO MYCOBACTERIAL DISEASES DUE TO PARTIAL IRF8 DEFICIENCY	0.0285714	2.8235264819378267
PROPIONIC ACIDEMIA	0.0285714	2.8235264819378267
127200 DWARFISM WITH STIFF JOINTS AND OCULAR ABNORMALITIES;;MOORE-FEDERMAN SYNDROME	0.0259601	2.5654686093000056
%609052 SPONDYLOMETAPHYSEAL DYSPLASIA, TYPE A4	0.0259601	2.5654686093000056
DESBUQUOIS DYSPLASIA 1	0.0259601	2.5654686093000056
DESBUQUOIS SYNDROME	0.0259601	2.5654686093000056
SHORT STATURE AND ADVANCED BONE AGE, WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS; SSOAOD	0.02565189	2.5350102104466745
ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1; GACI1	0.02565189	2.5350102104466745
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.02565189	2.5350102104466745
EPIPHYSEAL DYSPLASIA, BAUMANN TYPE	0.025	2.4705881422837406
LATERALITY DEFECTS, AUTOSOMAL DOMINANT	0.025	2.4705881422837406
ZIMMERMANN-LABAND SYNDROME 1	0.025	2.4705881422837406
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.025	2.4705881422837406
ZUNICH NEUROECTODERMAL SYNDROME	0.025	2.4705881422837406
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.025	2.4705881422837406
HOOFT DISEASE	0.025	2.4705881422837406
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.025	2.4705881422837406
MARFANOID HYPERMOBILITY SYNDROME	0.025	2.4705881422837406
ALKAPTONURIA	0.025	2.4705881422837406
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	0.025	2.4705881422837406
202155 ADRENAL HYPOPLASIA, CYTOMEGALIC TYPE	0.025	2.4705881422837406
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.025	2.4705881422837406
ANDROGEN INSENSITIVITY SYNDROME	0.025	2.4705881422837406
MAPLE SYRUP URINE DISEASE; MSUD	0.025	2.4705881422837406
MUCOPOLYSACCHARIDOSES, UNCLASSIFIED TYPES	0.025	2.4705881422837406
CZECH DYSPLASIA, METATARSAL TYPE	0.025	2.4705881422837406
248110 MACROSOMIA WITH MICROPHTHALMIA, LETHAL	0.025	2.4705881422837406
ENDOSTEAL HYPEROSTOSIS, AUTOSOMAL DOMINANT	0.025	2.4705881422837406
GROWTH CONTROL, Y-CHROMOSOME INFLUENCED	0.025	2.4705881422837406
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.025	2.4705881422837406
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.025	2.4705881422837406
COMBINED INFLAMMATORY AND IMMUNOLOGIC DEFECT	0.025	2.4705881422837406
CLEFT-LIMB-HEART MALFORMATION SYNDROME	0.025	2.4705881422837406
274210 THYMIC APLASIA WITH FETAL DEATH	0.025	2.4705881422837406
OSTEOGENESIS IMPERFECTA, TYPE I	0.025	2.4705881422837406
KEUTEL SYNDROME; KTLS	0.025	2.4705881422837406
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.0228938	2.26244603247262
CLASSICAL EHLERS-DANLOS SYNDROME	0.02236061	2.2097543168092493
BERNARD-SOULIER SYNDROME	0.02170872	2.1453322486463153
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.02089104	2.064526228159013
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.02089104	2.064526228159013
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE	0.0188679	1.8645924003918155
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MATRILIN-3 TYPE	0.0188679	1.8645924003918155
LERI-WEILL DYSCHONDROSTOSIS (LWD) - SHOX DELETION	0.0188679	1.8645924003918155
ACROMESOMELIC DYSPLASIA, DEMIRHAN TYPE; AMDD	0.0188679	1.8645924003918155
ACROMESOMELIC DYSPLASIA, GREBE TYPE	0.0188679	1.8645924003918155
PSEUDOACHONDROPLASIA	0.0188679	1.8645924003918155
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.0188679	1.8645924003918155
HEMIMELIA	0.0188679	1.8645924003918155
THORACOMELIC DYSPLASIA	0.0188679	1.8645924003918155
MADELUNG DEFORMITY	0.0188679	1.8645924003918155
CHONDRODYSPLASIA, LETHAL, WITH LONG BONE ANGULATION AND MIXED BONE DENSITY	0.0188679	1.8645924003918155
LERI-WEILL DYSCHONDROSTEOSIS	0.0188679	1.8645924003918155
CONGENITAL OSTEOGENESIS IMPERFECTA-MICROCEPHALY-CATARACTS SYNDROME	0.0188679	1.8645924003918155
PLATYSPONDYLIC DYSPLASIA, TORRANCE TYPE	0.0188679	1.8645924003918155
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, IRAPA TYPE	0.0188679	1.8645924003918155
THANATOPHORIC DYSPLASIA	0.0188679	1.8645924003918155
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE; DDSH	0.0188679	1.8645924003918155
SCHNECKENBECKEN DYSPLASIA	0.0188679	1.8645924003918155
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SPONASTRIME TYPE; SEMDSP	0.0188679	1.8645924003918155
ASTLEY-KENDALL DYSPLASIA	0.0188679	1.8645924003918155
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.0188679	1.8645924003918155
SCHNECKENBECKEN DYSPLASIA	0.0188679	1.8645924003918155
THORACOMELIC DYSPLASIA	0.0188679	1.8645924003918155
ACHONDROGENESIS TYPE 2	0.0188679	1.8645924003918155
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.0188679	1.8645924003918155
METAPHYSEAL DYSOSTOSIS-INTELLECTUAL DISABILITY-CONDUCTIVE DEAFNESS SYNDROME	0.0188679	1.8645924003918155
OSTEOGENESIS IMPERFECTA, TYPE IX	0.0188679	1.8645924003918155
OSTEOGENESIS IMPERFECTA CONGENITA, MICROCEPHALY, AND CATARACTS	0.0188679	1.8645924003918155
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MICROMELIC	0.0188679	1.8645924003918155
SLC39A8-CDG	0.0188679	1.8645924003918155
LÉRI-WEILL DYSCHONDROSTEOSIS	0.0188679	1.8645924003918155
HYPOPHOSPHATASIA, INFANTILE	0.0188679	1.8645924003918155
SHORT RIB-POLYDACTYLY SYNDROME, VERMA-NAUMOFF TYPE	0.0188679	1.8645924003918155
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.0188679	1.8645924003918155
OSTEOGENESIS IMPERFECTA, TYPE XIX; OI19	0.0180812	1.7868479327304307
PSEUDODIASTROPHIC DYSPLASIA	0.0180812	1.7868479327304307
DISTAL TRISOMY 17Q	0.0180812	1.7868479327304307
OSTEOGLOSPHONIC DYSPLASIA	0.0180812	1.7868479327304307
SPONDYLOMETAPHYSEAL DYSPLASIA-CONE-ROD DYSTROPHY SYNDROME	0.0180812	1.7868479327304307
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.0180812	1.7868479327304307
HYPERTRICHOSIS CUBITI	0.0180812	1.7868479327304307
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.01789329	1.7682780040177692
SYSTEMIC MASTOCYTOSIS	0.01728114	1.7077831827658096
PRIMARY CILIARY DYSKINESIA	0.01728114	1.7077831827658096
CUTANEOUS MASTOCYTOSIS	0.01728114	1.7077831827658096
TRANSSEXUALITY	0.0172414	1.7038559358548355
CARDIAC ARRHYTHMIA	0.0172414	1.7038559358548355
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	1.7038559358548355
269800 SENILE PLAQUE FORMATION	0.0172414	1.7038559358548355
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	1.7038559358548355
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0172414	1.7038559358548355
THUMBS, CONGENITAL CLASPED	0.0172414	1.7038559358548355
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	1.7038559358548355
CERVICAL RIB	0.0172414	1.7038559358548355
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	1.7038559358548355
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	1.7038559358548355
CONGENITAL TRACHEAL STENOSIS	0.0172414	1.7038559358548355
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	1.7038559358548355
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	1.7038559358548355
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	1.7038559358548355
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0172414	1.7038559358548355
ANDROSTENONE, ABILITY TO SMELL	0.0172414	1.7038559358548355
MYOPATHY, CONGENITAL	0.0172414	1.7038559358548355
ALCOHOL DEPENDENCE	0.0172414	1.7038559358548355
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	1.7038559358548355
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	1.7038559358548355
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	1.7038559358548355
SPASTIC PSEUDOSCLEROSIS	0.0172414	1.7038559358548355
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	1.7038559358548355
ENDOCARDIAL FIBROELASTOSIS	0.0172414	1.7038559358548355
MOTION SICKNESS	0.0172414	1.7038559358548355
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0172414	1.7038559358548355
JUMPING FRENCHMAN OF MAINE	0.0172414	1.7038559358548355
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	1.7038559358548355
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	1.7038559358548355
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	1.7038559358548355
PALMOMENTAL REFLEX	0.0172414	1.7038559358548355
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	1.7038559358548355
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0172414	1.7038559358548355
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	1.7038559358548355
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	1.7038559358548355
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	1.7038559358548355
SICKLE CELL ANEMIA	0.0172414	1.7038559358548355
ERYTHERMALGIA, PRIMARY	0.0172414	1.7038559358548355
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	1.7038559358548355
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	1.7038559358548355
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	1.7038559358548355
DIASTEMATOMYELIA	0.0172414	1.7038559358548355
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	1.7038559358548355
MOSAIC TRISOMY 15	0.0172414	1.7038559358548355
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	1.7038559358548355
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	1.7038559358548355
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 12; MGR12	0.015180260000000001	1.5001668141113673
CINCA SYNDROME	0.01345356	1.3295282323001136
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.01345356	1.3295282323001136
CYCLIC VOMITING SYNDROME	0.01345356	1.3295282323001136
PGM3-CDG	0.012556689999999999	1.2408963768133128
49,XXXXY SYNDROME	0.012556689999999999	1.2408963768133128
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.012556689999999999	1.2408963768133128
DUBOWITZ SYNDROME	0.012556689999999999	1.2408963768133128
CHROMOSOME 18Q DELETION SYNDROME	0.012556689999999999	1.2408963768133128
CASPASE 8 DEFICIENCY	0.012556689999999999	1.2408963768133128
SECKEL SYNDROME 9; SCKL9	0.012556689999999999	1.2408963768133128
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.012556689999999999	1.2408963768133128
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.012556689999999999	1.2408963768133128
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.012556689999999999	1.2408963768133128
ALSTROM SYNDROME; ALMS	0.012556689999999999	1.2408963768133128
MYOTONIA PERMANENS	0.012556689999999999	1.2408963768133128
IMMUNODEFICIENCY 58; IMD58	0.012556689999999999	1.2408963768133128
22Q11.2 DELETION SYNDROME	0.012556689999999999	1.2408963768133128
NETHERTON SYNDROME	0.012556689999999999	1.2408963768133128
STÜVE-WIEDEMANN SYNDROME	0.012556689999999999	1.2408963768133128
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.012556689999999999	1.2408963768133128
ALSTRÖM SYNDROME	0.012556689999999999	1.2408963768133128
OCULO-PALATO-CEREBRAL SYNDROME	0.012556689999999999	1.2408963768133128
BRAIN-LUNG-THYROID SYNDROME	0.012556689999999999	1.2408963768133128
16P13.2 MICRODELETION SYNDROME	0.012556689999999999	1.2408963768133128
MICROFORM HOLOPROSENCEPHALY	0.012556689999999999	1.2408963768133128
ASTHMA, SHORT STATURE, AND ELEVATED IGA	0.012556689999999999	1.2408963768133128
ECTODERMAL DYSPLASIA/SHORT STATURE SYNDROME	0.012556689999999999	1.2408963768133128
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.011904799999999998	1.176474308650379
YAO SYNDROME	0.011904799999999998	1.176474308650379
IMMUNODEFICIENCY 11B WITH ATOPIC DERMATITIS; IMD11B	0.011904799999999998	1.176474308650379
CHILBLAIN LUPUS	0.011904799999999998	1.176474308650379
MYELOPROLIFERATIVE/LYMPHOPROLIFERATIVE NEOPLASMS, FAMILIAL (MULTIPLE TYPES), SUSCEPTIBILITY TO; MPLPF	0.011904799999999998	1.176474308650379
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	0.011904799999999998	1.176474308650379
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.011904799999999998	1.176474308650379
48,XXXY SYNDROME	0.011904799999999998	1.176474308650379
47,XYY SYNDROME	0.011904799999999998	1.176474308650379
CILIARY DYSKINESIA, PRIMARY, 30; CILD30	0.011904799999999998	1.176474308650379
IMMUNODEFICIENCY 23; IMD23	0.011904799999999998	1.176474308650379
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.011904799999999998	1.176474308650379
614262 ARTHROGRYPOSIS, PERTHES DISEASE, AND UPWARD GAZE PALSY; APUG	0.011904799999999998	1.176474308650379
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 3; FCAS3	0.011904799999999998	1.176474308650379
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.011904799999999998	1.176474308650379
CYSTIC FIBROSIS	0.011904799999999998	1.176474308650379
EHLERS-DANLOS SYNDROME, AUTOSOMAL DOMINANT, TYPE UNSPECIFIED	0.011904799999999998	1.176474308650379
BRONCHIAL NEUROENDOCRINE TUMOR	0.011904799999999998	1.176474308650379
COMBINED IMMUNODEFICIENCY DUE TO DOCK8 DEFICIENCY	0.011904799999999998	1.176474308650379
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.011904799999999998	1.176474308650379
ICHTHYOSIS VULGARIS	0.011904799999999998	1.176474308650379
KERATOSIS PILARIS ATROPHICANS	0.011904799999999998	1.176474308650379
AGGRESSIVE SYSTEMIC MASTOCYTOSIS	0.011904799999999998	1.176474308650379
PRIMARY PULMONARY HYPOPLASIA	0.011904799999999998	1.176474308650379
48,XYYY SYNDROME	0.011904799999999998	1.176474308650379
EOSINOPHILIC GASTROENTERITIS	0.011904799999999998	1.176474308650379
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.011904799999999998	1.176474308650379
NETHERTON SYNDROME; NETH	0.011904799999999998	1.176474308650379
NEUTROPHIL CHEMOTACTIC RESPONSE	0.011904799999999998	1.176474308650379
ASTHMA, SUSCEPTIBILITY TO	0.011904799999999998	1.176474308650379
PERIPARTUM CARDIOMYOPATHY	0.011904799999999998	1.176474308650379
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS	0.011904799999999998	1.176474308650379
POTASSIUM-AGGRAVATED MYOTONIA	0.011904799999999998	1.176474308650379
IGE RESPONSIVENESS, ATOPIC	0.011904799999999998	1.176474308650379
9Q33.3Q34.11 MICRODELETION SYNDROME	0.011904799999999998	1.176474308650379
BARDET-BIEDL SYNDROME 1; BBS1	0.011904799999999998	1.176474308650379
TRANSALDOLASE DEFICIENCY	0.011904799999999998	1.176474308650379
NEUROENDOCRINE NEOPLASM OF APPENDIX	0.011904799999999998	1.176474308650379
ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS	0.011904799999999998	1.176474308650379
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.011904799999999998	1.176474308650379
48,XXYY SYNDROME	0.011904799999999998	1.176474308650379
MASTOCYTOSIS	0.011904799999999998	1.176474308650379
CARCINOID SYNDROME	0.011904799999999998	1.176474308650379
DERMATITIS, ATOPIC	0.011904799999999998	1.176474308650379
AORTIC ARCH DEFECTS	0.011904799999999998	1.176474308650379
SPONDYLOMETAPHYSEAL DYSPLASIA, AXIAL; SMDAX	0.011640890000000001	1.150393791985175
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.011640890000000001	1.150393791985175
SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY; SRTD5	0.010989	1.085971723822241
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE; SEMDAG	0.010989	1.085971723822241
PETERS PLUS SYNDROME	0.010989	1.085971723822241
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 3	0.010989	1.085971723822241
CHONDRODYSPLASIA WITH PLATYSPONDYLY, DISTINCTIVE BRACHYDACTYLY, HYDROCEPHALY, AND MICROPHTHALMIA	0.010989	1.085971723822241
ATELOSTEOGENESIS, TYPE I; AO1	0.010989	1.085971723822241
INIENCEPHALY	0.010989	1.085971723822241
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.010989	1.085971723822241
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.010989	1.085971723822241
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.010989	1.085971723822241
OSTEOCHONDRODYSPLASIA, RHIZOMELIC, WITH CALLOSAL AGENESIS, THROMBOCYTOPENIA,HYDROCEPHALUS, AND HYPERTENSION	0.010989	1.085971723822241
AUTOSOMAL DOMINANT MYOPIA-MIDFACIAL RETRUSION-SENSORINEURAL HEARING LOSS-RHIZOMELIC DYSPLASIA SYNDROME	0.010989	1.085971723822241
RHIZOMELIC DYSPLASIA, PATTERSON-LOWRY TYPE	0.010989	1.085971723822241
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	0.010989	1.085971723822241
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH HYPOTRICHOSIS	0.010989	1.085971723822241
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.010989	1.085971723822241
ASPHYXIATING THORACIC DYSTROPHY 2; ATD2	0.010989	1.085971723822241
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.010989	1.085971723822241
610319 RHIZOMELIC DYSPLASIA, SCOLIOSIS, AND RETINITIS PIGMENTOSA	0.010989	1.085971723822241
X-LINKED DOMINANT CHONDRODYSPLASIA PUNCTATA	0.010989	1.085971723822241
SPONDYLOENCHONDRODYSPLASIA	0.010989	1.085971723822241
CRANIOECTODERMAL DYSPLASIA 1	0.010989	1.085971723822241
SMITH-LEMLI-OPITZ SYNDROME	0.010989	1.085971723822241
FIBROCHONDROGENESIS 1; FBCG1	0.010989	1.085971723822241
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	0.010989	1.085971723822241
SPONASTRIME DYSPLASIA	0.010989	1.085971723822241
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.010989	1.085971723822241
SHORT-RIB THORACIC DYSPLASIA 13 WITH OR WITHOUT POLYDACTYLY; SRTD13	0.010989	1.085971723822241
CLOVERLEAF SKULL-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.010989	1.085971723822241
OSTEOGENESIS IMPERFECTA, TYPE XVI; OI16	0.010989	1.085971723822241
CLEIDORHIZOMELIC SYNDROME	0.010989	1.085971723822241
RHIZOMELIC DYSPLASIA, PATTERSON-LOWRY TYPE	0.010989	1.085971723822241
SPONDYLOEPIPHYSEAL DYSPLASIA AND SPONDYLOEPIMETAPHYSEAL DYSPLASIA	0.010989	1.085971723822241
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.010989	1.085971723822241
RHIZOMELIC SYNDROME, URBACH TYPE	0.010989	1.085971723822241
MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS	0.010989	1.085971723822241
CLEIDORHIZOMELIC SYNDROME	0.010989	1.085971723822241
SPONDYLOMETAPHYSEAL DYSPLASIA	0.010989	1.085971723822241
AUTOSOMAL RECESSIVE OMODYSPLASIA	0.010989	1.085971723822241
AUTOSOMAL DOMINANT OMODYSPLASIA	0.010989	1.085971723822241
MULTIPLE EPIPHYSEAL DYSPLASIA, LOWRY TYPE	0.010989	1.085971723822241
X-LINKED DOMINANT CHONDRODYSPLASIA, CHASSAING-LACOMBE TYPE	0.010989	1.085971723822241
AXIAL SPONDYLOMETAPHYSEAL DYSPLASIA	0.010989	1.085971723822241
COG1-CDG	0.010989	1.085971723822241
CARTILAGE-HAIR HYPOPLASIA	0.010989	1.085971723822241
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.010989	1.085971723822241
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS	0.010989	1.085971723822241
WIEDEMANN-STEINER SYNDROME	0.010989	1.085971723822241
CRANIOECTODERMAL DYSPLASIA	0.010989	1.085971723822241
PSEUDODIASTROPHIC DYSPLASIA	0.010989	1.085971723822241
SHORT RIB-POLYDACTYLY SYNDROME	0.010989	1.085971723822241
RHIZOMELIC SYNDROME	0.010989	1.085971723822241
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.010989	1.085971723822241
SMITH-KINGSMORE SYNDROME; SKS	0.010989	1.085971723822241
STORMORKEN SYNDROME; STRMK	0.010455810000000001	1.0332800081588704
VASCULAR EHLERS-DANLOS SYNDROME	0.010455810000000001	1.0332800081588704
BLACKFAN-DIAMOND ANEMIA	0.010455810000000001	1.0332800081588704
HARTNUP DISEASE	0.010455810000000001	1.0332800081588704
SAETHRE-CHOTZEN SYNDROME	0.010455810000000001	1.0332800081588704
MELAS	0.010455810000000001	1.0332800081588704
EPENDYMOMA	0.00980392	0.9688579399959365
SUBEPENDYMOMA	0.00980392	0.9688579399959365
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.00980392	0.9688579399959365
CITRULLINEMIA TYPE I	0.00980392	0.9688579399959365
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.00980392	0.9688579399959365
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00980392	0.9688579399959365
PERIODIC FEVER, MENSTRUAL CYCLE-DEPENDENT	0.00980392	0.9688579399959365
EPISODIC ATAXIA TYPE 7	0.00980392	0.9688579399959365
KERION CELSI	0.00980392	0.9688579399959365
NEUROFIBROMATOSIS TYPE 2	0.00980392	0.9688579399959365
SYSTEMIC SCLEROSIS	0.00980392	0.9688579399959365
VON HIPPEL-LINDAU DISEASE	0.00980392	0.9688579399959365
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.00980392	0.9688579399959365
CROUZON SYNDROME-ACANTHOSIS NIGRICANS SYNDROME	0.00980392	0.9688579399959365
LEGIONELLOSIS	0.00980392	0.9688579399959365
ROLANDIC EPILEPSY	0.00980392	0.9688579399959365
MICROCEPHALY-FACIAL DYSMORPHISM-OCULAR ANOMALIES-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.00980392	0.9688579399959365
PULMONARY ARTERIOVENOUS MALFORMATION	0.00980392	0.9688579399959365
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.00980392	0.9688579399959365
LYNCH SYNDROME	0.00980392	0.9688579399959365
EPISODIC ATAXIA TYPE 6	0.00980392	0.9688579399959365
MALIGNANT ATROPHIC PAPULOSIS	0.00980392	0.9688579399959365
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.00980392	0.9688579399959365
ARACHNOIDITIS	0.00980392	0.9688579399959365
CADASIL	0.00980392	0.9688579399959365
KAWASAKI DISEASE	0.00980392	0.9688579399959365
DISTAL 16P11.2 MICRODELETION SYNDROME	0.00980392	0.9688579399959365
SNEDDON SYNDROME	0.00980392	0.9688579399959365
PAROXYSMAL KINESIGENIC DYSKINESIA	0.00980392	0.9688579399959365
WALDENSTRÖM MACROGLOBULINEMIA	0.00980392	0.9688579399959365
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.00980392	0.9688579399959365
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.00980392	0.9688579399959365
FAMILIAL CERVICAL ARTERY DISSECTION	0.00980392	0.9688579399959365
VIRAL HEMORRHAGIC FEVER	0.00980392	0.9688579399959365
HEMORRHAGIC FEVER-RENAL SYNDROME	0.00980392	0.9688579399959365
EPISODIC ATAXIA, TYPE 6	0.00980392	0.9688579399959365
RHEUMATIC FEVER	0.00980392	0.9688579399959365
SOMATOMAMMOTROPINOMA	0.00980392	0.9688579399959365
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 5; IBGC5	0.00980392	0.9688579399959365
CLASSIC HODGKIN LYMPHOMA	0.00980392	0.9688579399959365
TUMOR NECROSIS FACTOR RECEPTOR 1 ASSOCIATED PERIODIC SYNDROME	0.00980392	0.9688579399959365
INFANTILE CONVULSIONS AND CHOREOATHETOSIS	0.00980392	0.9688579399959365
ADULT-ONSET CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL MYOPATHY	0.00980392	0.9688579399959365
DEAFNESS-LYMPHEDEMA-LEUKEMIA SYNDROME	0.00980392	0.9688579399959365
TAKAYASU ARTERITIS	0.00980392	0.9688579399959365
ABETAL34V AMYLOIDOSIS	0.00980392	0.9688579399959365
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.00980392	0.9688579399959365
PEROXISOME BIOGENESIS DISORDER 14B	0.00980392	0.9688579399959365
BENIGN FAMILIAL INFANTILE EPILEPSY	0.00980392	0.9688579399959365
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.00980392	0.9688579399959365
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.00980392	0.9688579399959365
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.00980392	0.9688579399959365
PHACE ASSOCIATION	0.00980392	0.9688579399959365
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.00980392	0.9688579399959365
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 7, AUTOSOMAL RECESSIVE; IBGC7	0.00980392	0.9688579399959365
SPINOCEREBELLAR ATAXIA TYPE 36	0.00980392	0.9688579399959365
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.00980392	0.9688579399959365
FAMILIAL PAROXYSMAL ATAXIA	0.00980392	0.9688579399959365
ACROMEGALY	0.00980392	0.9688579399959365
FAMILIAL COLORECTAL CANCER TYPE X	0.00980392	0.9688579399959365
BENIGN PAROXYSMAL TORTICOLLIS OF INFANCY	0.00980392	0.9688579399959365
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.00980392	0.9688579399959365
PFAPA SYNDROME	0.00980392	0.9688579399959365
MALAN OVERGROWTH SYNDROME	0.00980392	0.9688579399959365
ANEURYSM-OSTEOARTHRITIS SYNDROME	0.00980392	0.9688579399959365
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.00980392	0.9688579399959365
EPISODIC ATAXIA WITH SLURRED SPEECH	0.00980392	0.9688579399959365
IMMUNOGLOBULIN A VASCULITIS	0.00980392	0.9688579399959365
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 4; HHT4	0.00980392	0.9688579399959365
RABIES	0.00980392	0.9688579399959365
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 4; IBGC4	0.00980392	0.9688579399959365
ATYPICAL TERATOID RHABDOID TUMOR	0.00980392	0.9688579399959365
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.00980392	0.9688579399959365
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.00980392	0.9688579399959365
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.00980392	0.9688579399959365
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.00980392	0.9688579399959365
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.00980392	0.9688579399959365
EPISODIC ATAXIA, TYPE 2	0.00980392	0.9688579399959365
OPTIC PATHWAY GLIOMA	0.00902598	0.8919791664196078
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.00902598	0.8919791664196078
BANGSTAD SYNDROME	0.00774409	0.7652982770711237
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.0070922	0.7008762089081898
METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE	0.0070922	0.7008762089081898
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.0070922	0.7008762089081898
RENPENNING SYNDROME	0.0070922	0.7008762089081898
DEAFNESS-VITILIGO-ACHALASIA SYNDROME	0.0070922	0.7008762089081898
INFANTILE SYSTEMIC HYALINOSIS	0.0070922	0.7008762089081898
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.0070922	0.7008762089081898
CARDIOSPONDYLOCARPOFACIAL SYNDROME	0.0070922	0.7008762089081898
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.0070922	0.7008762089081898
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.0070922	0.7008762089081898
SECKEL SYNDROME 10; SCKL10	0.0070922	0.7008762089081898
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.0070922	0.7008762089081898
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.0070922	0.7008762089081898
FILIPPI SYNDROME	0.0070922	0.7008762089081898
MULTIPLE PTERYGIUM-MALIGNANT HYPERTHERMIA SYNDROME	0.0070922	0.7008762089081898
MULCHANDANI-BHOJ-CONLIN SYNDROME	0.0070922	0.7008762089081898
JOHNSON NEUROECTODERMAL SYNDROME	0.0070922	0.7008762089081898
DWARFISM, PROPORTIONATE, WITH HIP DISLOCATION	0.0070922	0.7008762089081898
ICHTHYOSIS, MENTAL RETARDATION, DWARFISM, AND RENAL IMPAIRMENT	0.0070922	0.7008762089081898
223540 DWARFISM, MENTAL RETARDATION, AND EYE ABNORMALITY;;MOLLICA SYNDROME	0.0070922	0.7008762089081898
IVIC SYNDROME	0.0070922	0.7008762089081898
DWARFISM, LOW-BIRTH-WEIGHT TYPE, WITH UNRESPONSIVENESS TO GROWTH HORMONE	0.0070922	0.7008762089081898
OPSISMODYSPLASIA	0.0070922	0.7008762089081898
DE SANCTIS-CACCHIONE SYNDROME	0.0070922	0.7008762089081898
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.0070922	0.7008762089081898
ICHTHYOSIS-INTELLECTUAL DISABILITY-DWARFISM-RENAL IMPAIRMENT SYNDROME	0.0070922	0.7008762089081898
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.0070922	0.7008762089081898
OROFACIODIGITAL SYNDROME TYPE 4	0.0070922	0.7008762089081898
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.0070922	0.7008762089081898
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.0070922	0.7008762089081898
DWARFISM WITH TALL VERTEBRAE	0.0070922	0.7008762089081898
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.0070922	0.7008762089081898
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.0070922	0.7008762089081898
METATROPIC DYSPLASIA	0.0070922	0.7008762089081898
SPASTIC PARAPLEGIA-NEPHRITIS-DEAFNESS SYNDROME	0.0070922	0.7008762089081898
PTOSIS-VOCAL CORD PARALYSIS SYNDROME	0.0070922	0.7008762089081898
ACHONDROGENESIS TYPE 1A	0.0070922	0.7008762089081898
MEIER-GORLIN SYNDROME 6; MGORS6	0.0070922	0.7008762089081898
XFE PROGEROID SYNDROME; XFEPS	0.0070922	0.7008762089081898
RADIO-RENAL SYNDROME	0.0070922	0.7008762089081898
METAPHYSEAL ACROSCYPHODYSPLASIA	0.0070922	0.7008762089081898
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.0070922	0.7008762089081898
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.0070922	0.7008762089081898
AUTOSOMAL DOMINANT SPONDYLOCOSTAL DYSOSTOSIS	0.0070922	0.7008762089081898
ACHONDROGENESIS	0.0070922	0.7008762089081898
EVEN-PLUS SYNDROME	0.0070922	0.7008762089081898
SHORT SYNDROME	0.0070922	0.7008762089081898
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.0070922	0.7008762089081898
SPONDYLOMETAPHYSEAL DYSPLASIA, A4 TYPE	0.0070922	0.7008762089081898
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.0070922	0.7008762089081898
SYNDESMODYSPLASIC DWARFISM	0.0070922	0.7008762089081898
MEGAEPIPHYSEAL DWARFISM	0.0070922	0.7008762089081898
ARTHROCHALASIA EHLERS-DANLOS SYNDROME	0.0070922	0.7008762089081898
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE	0.0070922	0.7008762089081898
JUBERG-HAYWARD SYNDROME	0.0070922	0.7008762089081898
GERODERMA OSTEODYSPLASTICA	0.0070922	0.7008762089081898
ALAZAMI SYNDROME; ALAZS	0.0070922	0.7008762089081898
BOOMERANG DYSPLASIA	0.0070922	0.7008762089081898
CALVARIAL DOUGHNUT LESIONS WITH BONE FRAGILITY; CDL	0.0070922	0.7008762089081898
CORNEODERMATOOSSEOUS SYNDROME	0.0070922	0.7008762089081898
%112350 WEISMANN-NETTER SYNDROME; WNS;;BOWING OF LEGS, ANTERIOR, WITH DWARFISM;;TOXOPACHYOSTEOSE DIAPHYSAIRE TIBIO-PERONIERE	0.0070922	0.7008762089081898
DERMATOSPARAXIS EHLERS-DANLOS SYNDROME	0.0070922	0.7008762089081898
CLEIDOCRANIAL DYSPLASIA, RECESSIVE FORM	0.0070922	0.7008762089081898
CHONDRODYSPLASIA CALCIFICANS METAPHYSEALIS	0.0070922	0.7008762089081898
MORQUIO SYNDROME C	0.0070922	0.7008762089081898
LERI PLEONOSTEOSIS	0.0070922	0.7008762089081898
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 1	0.0070922	0.7008762089081898
MARINESCO-SJÖGREN SYNDROME	0.0070922	0.7008762089081898
DWARFISM, LEVI TYPE	0.0070922	0.7008762089081898
CHONDRODYSPLASIA-DISORDER OF SEX DEVELOPMENT SYNDROME	0.0070922	0.7008762089081898
BRACHYDACTYLOUS DWARFISM, MSELENI TYPE	0.0070922	0.7008762089081898
ALOPECIA-CONTRACTURES-DWARFISM-INTELLECTUAL DISABILITY SYNDROME	0.0070922	0.7008762089081898
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.0070922	0.7008762089081898
BULLOUS DYSTROPHY, HEREDITARY MACULAR TYPE	0.0070922	0.7008762089081898
MARDEN-WALKER SYNDROME	0.0070922	0.7008762089081898
ACROMICRIC DYSPLASIA	0.0070922	0.7008762089081898
ALOPECIA-CONTRACTURES-DWARFISM MENTAL RETARDATION SYNDROME	0.0070922	0.7008762089081898
ACROMICRIC DYSPLASIA	0.0070922	0.7008762089081898
ALANINURIA WITH MICROCEPHALY, DWARFISM, ENAMEL HYPOPLASIA, AND DIABETES MELLITUS	0.0070922	0.7008762089081898
RAMOS-ARROYO SYNDROME	0.0070922	0.7008762089081898
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.0070922	0.7008762089081898
LARON SYNDROME	0.0070922	0.7008762089081898
EAR-PATELLA-SHORT STATURE SYNDROME	0.0070922	0.7008762089081898
DESMOSTEROLOSIS	0.0070922	0.7008762089081898
SPONDYLOMETAPHYSEAL DYSPLASIA, ALGERIAN TYPE	0.0070922	0.7008762089081898
METAPHYSEAL ACROSCYPHODYSPLASIA	0.0070922	0.7008762089081898
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.0070922	0.7008762089081898
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.0070922	0.7008762089081898
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.0070922	0.7008762089081898
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.0070922	0.7008762089081898
KERATOSIS FOLLICULARIS, DWARFISM, AND CEREBRAL ATROPHY	0.0070922	0.7008762089081898
OLIVER-MCFARLANE SYNDROME	0.0070922	0.7008762089081898
DWARFISM, FAMILIAL, WITH MUSCLE SPASMS	0.0070922	0.7008762089081898
GERODERMA OSTEODYSPLASTICUM; GO	0.0070922	0.7008762089081898
MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.0070922	0.7008762089081898
CHONDRODYSPLASIA-PSEUDOHERMAPHRODITISM SYNDROME	0.0070922	0.7008762089081898
ENCEPHALOPATHY WITH INTRACRANIAL CALCIFICATION, GROWTH HORMONE DEFICIENCY, MICROCEPHALY, AND RETINAL DEGENERATION	0.0070922	0.7008762089081898
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.0070922	0.7008762089081898
LARON SYNDROME	0.0070922	0.7008762089081898
METATROPIC DYSPLASIA	0.0070922	0.7008762089081898
WEISMANN-NETTER SYNDROME	0.0070922	0.7008762089081898
SYNOVIAL CHONDROMATOSIS, FAMILIAL, WITH DWARFISM	0.0070922	0.7008762089081898
SECKEL SYNDROME 7; SCKL7	0.0070922	0.7008762089081898
AMINO ACIDURIA WITH MENTAL DEFICIENCY, DWARFISM, MUSCULAR DYSTROPHY,OSTEOPOROSIS, AND ACIDOSIS	0.0070922	0.7008762089081898
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.0070922	0.7008762089081898
MIETENS SYNDROME	0.0070922	0.7008762089081898
TRYPTOPHANURIA WITH DWARFISM	0.0070922	0.7008762089081898
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.0070922	0.7008762089081898
KERATOSIS FOLLICULARIS-DWARFISM-CEREBRAL ATROPHY SYNDROME	0.0070922	0.7008762089081898
CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE III	0.006028230000000001	0.5957309422783647
RIDDLE SYNDROME	0.006028230000000001	0.5957309422783647
THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME	0.006028230000000001	0.5957309422783647
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.006028230000000001	0.5957309422783647
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.006028230000000001	0.5957309422783647
AICARDI-GOUTIÈRES SYNDROME	0.006028230000000001	0.5957309422783647
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.006028230000000001	0.5957309422783647
ACROOSTEOLYSIS DOMINANT TYPE	0.006028230000000001	0.5957309422783647
NARP SYNDROME	0.006028230000000001	0.5957309422783647
GRANULOMATOSIS WITH POLYANGIITIS	0.00537634	0.5313088741154307
CARNEY TRIAD	0.00537634	0.5313088741154307
ABETA AMYLOIDOSIS, DUTCH TYPE	0.00537634	0.5313088741154307
MIDDLE EAR NEUROENDOCRINE TUMOR	0.00537634	0.5313088741154307
DEAFNESS, SENSORINEURAL, WITH PERIPHERAL NEUROPATHY AND ARTERIAL DISEASE	0.00537634	0.5313088741154307
FAMILIAL HYPERALDOSTERONISM TYPE I	0.00537634	0.5313088741154307
LEPTOSPIROSIS	0.00537634	0.5313088741154307
FAMILIAL HYPERALDOSTERONISM TYPE II	0.00537634	0.5313088741154307
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.00537634	0.5313088741154307
AUTOIMMUNE HEMOLYTIC ANEMIA, WARM TYPE	0.00537634	0.5313088741154307
PAROXYSMAL COLD HEMOGLOBINURIA	0.00537634	0.5313088741154307
HYDROXYKYNURENINURIA	0.00537634	0.5313088741154307
DRUG-INDUCED AUTOIMMUNE HEMOLYTIC ANEMIA	0.00537634	0.5313088741154307
PRIMARY FAMILIAL POLYCYTHEMIA	0.00537634	0.5313088741154307
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.00537634	0.5313088741154307
PARKES WEBER SYNDROME	0.00537634	0.5313088741154307
X-LINKED ADRENOLEUKODYSTROPHY	0.00537634	0.5313088741154307
SNEDDON SYNDROME	0.00537634	0.5313088741154307
15Q OVERGROWTH SYNDROME	0.00537634	0.5313088741154307
PAROXYSMAL DYSTONIC CHOREATHETOSIS WITH EPISODIC ATAXIA AND SPASTICITY	0.00537634	0.5313088741154307
WYBURN-MASON SYNDROME	0.00537634	0.5313088741154307
SEVERE HEMOPHILIA A	0.00537634	0.5313088741154307
THYMIC TUMOR	0.00537634	0.5313088741154307
BABESIOSIS	0.00537634	0.5313088741154307
GIANT CELL ARTERITIS	0.00537634	0.5313088741154307
FAMILIAL COLD URTICARIA	0.00537634	0.5313088741154307
ENCEPHALITIS LETHARGICA	0.00537634	0.5313088741154307
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.00537634	0.5313088741154307
SUSAC SYNDROME	0.00537634	0.5313088741154307
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.00537634	0.5313088741154307
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.00537634	0.5313088741154307
PARIETAL FORAMINA	0.00537634	0.5313088741154307
LAFORA DISEASE	0.00537634	0.5313088741154307
PARATHYROID CARCINOMA	0.00537634	0.5313088741154307
MAJEED SYNDROME	0.00537634	0.5313088741154307
CAMURATI-ENGELMANN DISEASE	0.00537634	0.5313088741154307
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	0.00537634	0.5313088741154307
AMERICAN TRYPANOSOMIASIS	0.00537634	0.5313088741154307
NOCARDIOSIS	0.00537634	0.5313088741154307
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.00537634	0.5313088741154307
ACUTE RESPIRATORY CORONAVIRUS INFECTION	0.00537634	0.5313088741154307
SCRUB TYPHUS	0.00537634	0.5313088741154307
GITELMAN SYNDROME	0.00537634	0.5313088741154307
CUTANEOUS MASTOCYTOMA	0.00537634	0.5313088741154307
GLIOBLASTOMA	0.00537634	0.5313088741154307
MACULOPAPULAR CUTANEOUS MASTOCYTOSIS	0.00537634	0.5313088741154307
LUJO HEMORRHAGIC FEVER	0.00537634	0.5313088741154307
EBOLA HEMORRHAGIC FEVER	0.00537634	0.5313088741154307
DEAFNESS, AUTOSOMAL DOMINANT 34, WITH OR WITHOUT INFLAMMATION; DFNA34	0.00537634	0.5313088741154307
RIFT VALLEY FEVER	0.00537634	0.5313088741154307
ROSAÏ-DORFMAN DISEASE	0.00537634	0.5313088741154307
EPISODIC ATAXIA TYPE 1	0.00537634	0.5313088741154307
HYPER-IGD SYNDROME	0.00537634	0.5313088741154307
CRYPTOCOCCOSIS	0.00537634	0.5313088741154307
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2; FCAS2	0.00537634	0.5313088741154307
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.00537634	0.5313088741154307
PAPILLOMA OF CHOROID PLEXUS	0.00537634	0.5313088741154307
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.00537634	0.5313088741154307
ADIPOSIS DOLOROSA	0.00537634	0.5313088741154307
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.00537634	0.5313088741154307
RAT-BITE FEVER	0.00537634	0.5313088741154307
PITUITARY CARCINOMA	0.00537634	0.5313088741154307
TSH-SECRETING PITUITARY ADENOMA	0.00537634	0.5313088741154307
HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III	0.00537634	0.5313088741154307
ALPORT SYNDROME	0.00537634	0.5313088741154307
SACRAL DEFECT WITH ANTERIOR MENINGOCELE	0.00537634	0.5313088741154307
MYXOPAPILLARY EPENDYMOMA	0.00537634	0.5313088741154307
MEDULLOBLASTOMA	0.00537634	0.5313088741154307
PINEOBLASTOMA	0.00537634	0.5313088741154307
ECTOPIC ALDOSTERONE-PRODUCING TUMOR	0.00537634	0.5313088741154307
ADRENOCORTICAL CARCINOMA WITH PURE ALDOSTERONE HYPERSECRETION	0.00537634	0.5313088741154307
PRIMARY UNILATERAL ADRENAL HYPERPLASIA	0.00537634	0.5313088741154307
PINEOCYTOMA	0.00537634	0.5313088741154307
TYPHOID	0.00537634	0.5313088741154307
HUGHES-STOVIN SYNDROME	0.00537634	0.5313088741154307
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.00537634	0.5313088741154307
PANHYPOPHYSITIS	0.00537634	0.5313088741154307
ADENOHYPOPHYSITIS	0.00537634	0.5313088741154307
STEVENS-JOHNSON SYNDROME/TOXIC EPIDERMAL NECROLYSIS SPECTRUM	0.00537634	0.5313088741154307
L1 SYNDROME	0.00537634	0.5313088741154307
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.00537634	0.5313088741154307
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.00537634	0.5313088741154307
PONTIAC FEVER	0.00537634	0.5313088741154307
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.00537634	0.5313088741154307
PREECLAMPSIA	0.00537634	0.5313088741154307
GLUTAMATE MONOSODIUM SENSITIVITY	0.00537634	0.5313088741154307
PLAGUE	0.00537634	0.5313088741154307
PITUICYTOMA	0.00537634	0.5313088741154307
INTERNAL CAROTID AGENESIS	0.00537634	0.5313088741154307
ENAMEL HYPOPLASIA, CATARACTS, AND AQUEDUCTAL STENOSIS	0.00537634	0.5313088741154307
MENINGIOMA	0.00537634	0.5313088741154307
MARSILI SYNDROME; MARSIS	0.00537634	0.5313088741154307
RHABDOID TUMOR	0.00537634	0.5313088741154307
SECONDARY POLYCYTHEMIA	0.00537634	0.5313088741154307
AUTOIMMUNE HEMOLYTIC ANEMIA	0.00537634	0.5313088741154307
HODGKIN LYMPHOMA	0.00537634	0.5313088741154307
BENIGN OCCIPITAL EPILEPSY	0.00537634	0.5313088741154307
JUVENILE TEMPORAL ARTERITIS	0.00537634	0.5313088741154307
LHERMITTE-DUCLOS DISEASE	0.00537634	0.5313088741154307
MALARIA	0.00537634	0.5313088741154307
INDOLENT SYSTEMIC MASTOCYTOSIS	0.00537634	0.5313088741154307
POSTENCEPHALITIC PARKINSONISM	0.00537634	0.5313088741154307
SOLAR URTICARIA	0.00537634	0.5313088741154307
FAMILIAL HYPERALDOSTERONISM TYPE III	0.00537634	0.5313088741154307
NEUROFIBROMATOSIS, TYPE II	0.00537634	0.5313088741154307
PERINEURAL CYST	0.00537634	0.5313088741154307
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.00537634	0.5313088741154307
CUSHING DISEASE	0.00537634	0.5313088741154307
HELLP SYNDROME	0.00537634	0.5313088741154307
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.00537634	0.5313088741154307
CRANIOSYNOSTOSIS 2	0.00537634	0.5313088741154307
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.00537634	0.5313088741154307
PAPILLARY TUMOR OF THE PINEAL REGION	0.00537634	0.5313088741154307
YELLOW FEVER	0.00537634	0.5313088741154307
ACQUIRED METHEMOGLOBINEMIA	0.00537634	0.5313088741154307
GANGLIOCYTOMA	0.00537634	0.5313088741154307
CHIARI MALFORMATION TYPE I	0.00537634	0.5313088741154307
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1	0.00537634	0.5313088741154307
MANGANESE POISONING	0.00537634	0.5313088741154307
SYDENHAM CHOREA	0.00537634	0.5313088741154307
HEMANGIOBLASTOMA	0.00537634	0.5313088741154307
PRIMARY PARATHYROID HYPERPLASIA	0.00537634	0.5313088741154307
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.00537634	0.5313088741154307
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.00537634	0.5313088741154307
BRUNNER SYNDROME; BRNRS	0.00537634	0.5313088741154307
RELAPSING FEVER	0.00537634	0.5313088741154307
LYME DISEASE	0.00537634	0.5313088741154307
CENTRAL DIABETES INSIPIDUS	0.00537634	0.5313088741154307
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.00537634	0.5313088741154307
HYPERPARATHYROIDISM-JAW TUMOR SYNDROME	0.00537634	0.5313088741154307
EPISODIC ATAXIA, TYPE 1; EA1	0.00537634	0.5313088741154307
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.00537634	0.5313088741154307
NON-FUNCTIONING PITUITARY ADENOMA	0.00537634	0.5313088741154307
FUNCTIONING GONADOTROPIC ADENOMA	0.00537634	0.5313088741154307
PROLACTINOMA	0.00537634	0.5313088741154307
DENGUE FEVER	0.00537634	0.5313088741154307
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.00537634	0.5313088741154307
CRIMEAN-CONGO HEMORRHAGIC FEVER	0.00537634	0.5313088741154307
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.00537634	0.5313088741154307
FAMILIAL THROMBOCYTOSIS	0.00537634	0.5313088741154307
POSTORGASMIC ILLNESS SYNDROME	0.00537634	0.5313088741154307
TURCOT SYNDROME WITH POLYPOSIS	0.00537634	0.5313088741154307
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.00537634	0.5313088741154307
HYPERTHERMIA, CUTANEOUS, WITH HEADACHES AND NAUSEA	0.00537634	0.5313088741154307
IDIOPATHIC PANUVEITIS	0.00537634	0.5313088741154307
SCLEROSTEOSIS 1; SOST1	0.00537634	0.5313088741154307
EPISODIC ATAXIA, TYPE 3	0.00537634	0.5313088741154307
LASSA FEVER	0.00537634	0.5313088741154307
POLYCYTHEMIA VERA	0.00537634	0.5313088741154307
CROUZON DISEASE	0.00537634	0.5313088741154307
TEMPI SYNDROME	0.00537634	0.5313088741154307
COLD AGGLUTININ DISEASE	0.00537634	0.5313088741154307
NIPAH VIRUS DISEASE	0.00537634	0.5313088741154307
MARBURG HEMORRHAGIC FEVER	0.00537634	0.5313088741154307
POLYARTERITIS NODOSA, CHILDHOOD-ONSET	0.00537634	0.5313088741154307
CENTRAL NEUROCYTOMA	0.00537634	0.5313088741154307
OSTEOPETROSIS, AUTOSOMAL DOMINANT 1; OPTA1	0.00537634	0.5313088741154307
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.00537634	0.5313088741154307
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.00537634	0.5313088741154307
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.00430153	0.42509236046711113
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.00430153	0.42509236046711113
GLYCEROL KINASE DEFICIENCY; GKD	0.00430153	0.42509236046711113
GROWTH RETARDATION, DEAFNESS, FEMORAL EPIPHYSEAL DYSPLASIA, AND LACRIMAL DUCT OBSTRUCTION	0.00430153	0.42509236046711113
3MC SYNDROME 3	0.00430153	0.42509236046711113
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.00430153	0.42509236046711113
MICROSPHEROPHAKIA-METAPHYSEAL DYSPLASIA	0.00430153	0.42509236046711113
SECKEL SYNDROME 2; SCKL2	0.00430153	0.42509236046711113
WITTEVEEN-KOLK SYNDROME	0.00430153	0.42509236046711113
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.00364964	0.36067029230417724
FANCONI ANEMIA, COMPLEMENTATION GROUP R	0.00364964	0.36067029230417724
RING CHROMOSOME 14 SYNDROME	0.00364964	0.36067029230417724
CUSHING SYNDROME	0.00364964	0.36067029230417724
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.00364964	0.36067029230417724
RECOMBINANT CHROMOSOME 8 SYNDROME	0.00364964	0.36067029230417724
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.00364964	0.36067029230417724
ROWLEY-ROSENBERG SYNDROME	0.00364964	0.36067029230417724
HEREDITARY FRUCTOSE INTOLERANCE	0.00364964	0.36067029230417724
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.00364964	0.36067029230417724
MILLER-DIEKER SYNDROME	0.00364964	0.36067029230417724
FANCONI ANEMIA, COMPLEMENTATION GROUP U	0.00364964	0.36067029230417724
AUTOINFLAMMATION WITH ARTHRITIS AND DYSKERATOSIS; AIADK	0.00364964	0.36067029230417724
OSSEOUS HETEROPLASIA, PROGRESSIVE; POH	0.00364964	0.36067029230417724
AUTOSOMAL RECESSIVE MALIGNANT OSTEOPETROSIS	0.00364964	0.36067029230417724
FANCONI ANEMIA, COMPLEMENTATION GROUP W; FANCW	0.00364964	0.36067029230417724
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.00364964	0.36067029230417724
HEART AND BRAIN MALFORMATION SYNDROME	0.00364964	0.36067029230417724
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.00364964	0.36067029230417724
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.00364964	0.36067029230417724
MENTAL AND GROWTH RETARDATION WITH AMBLYOPIA	0.00364964	0.36067029230417724
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.00364964	0.36067029230417724
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.00364964	0.36067029230417724
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.00364964	0.36067029230417724
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.00364964	0.36067029230417724
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.00364964	0.36067029230417724
KLEEFSTRA SYNDROME 2; KLEFS2	0.00364964	0.36067029230417724
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.00364964	0.36067029230417724
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.00364964	0.36067029230417724
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.00364964	0.36067029230417724
COACH SYNDROME	0.00364964	0.36067029230417724
OSTEOPETROSIS AND RELATED DISORDERS	0.00364964	0.36067029230417724
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.00364964	0.36067029230417724
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.00364964	0.36067029230417724
LEUKOMELANODERMA, INFANTILISM, MENTAL RETARDATION, HYPODONTIA, HYPOTRICHOSIS	0.00364964	0.36067029230417724
CHYLOMICRON RETENTION DISEASE	0.00364964	0.36067029230417724
CRANIOSTENOSIS, SAGITTAL, WITH CONGENITAL HEART DISEASE, MENTAL DEFICIENCY, AND MANDIBULAR ANKYLOSIS	0.00364964	0.36067029230417724
LYSINE MALABSORPTION SYNDROME	0.00364964	0.36067029230417724
%217990 CORPUS CALLOSUM, AGENESIS OF;;ACC	0.00364964	0.36067029230417724
CITRULLINE TRANSPORT DEFECT	0.00364964	0.36067029230417724
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.00364964	0.36067029230417724
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.00364964	0.36067029230417724
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.00364964	0.36067029230417724
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.00364964	0.36067029230417724
JUVENILE POLYPOSIS SYNDROME	0.00364964	0.36067029230417724
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.00364964	0.36067029230417724
SEVERE CONGENITAL HYPOCHROMIC ANEMIA WITH RINGED SIDEROBLASTS	0.00364964	0.36067029230417724
FRANK-TER HAAR SYNDROME; FTHS	0.00364964	0.36067029230417724
SENGERS SYNDROME	0.00364964	0.36067029230417724
ROTHMUND-THOMSON SYNDROME TYPE 2	0.00364964	0.36067029230417724
INTERLEUKIN 1, DEFECTIVE T-CELL RESPONSE TO	0.00364964	0.36067029230417724
VICI SYNDROME; VICIS	0.00364964	0.36067029230417724
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.00364964	0.36067029230417724
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.00364964	0.36067029230417724
MICROGASTRIA-LIMB REDUCTION DEFECT SYNDROME	0.00364964	0.36067029230417724
GAPO SYNDROME; GAPOS	0.00364964	0.36067029230417724
14Q12 MICRODELETION SYNDROME	0.00364964	0.36067029230417724
LINEAR NEVUS SEBACEUS SYNDROME	0.00364964	0.36067029230417724
FORMIMINOTRANSFERASE DEFICIENCY	0.00364964	0.36067029230417724
20Q13.33 MICRODELETION SYNDROME	0.00364964	0.36067029230417724
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.00364964	0.36067029230417724
XP21 MICRODELETION SYNDROME	0.00364964	0.36067029230417724
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.00364964	0.36067029230417724
CONGENITAL PULMONARY LYMPHANGIECTASIA	0.00364964	0.36067029230417724
HYPERLYSINURIA WITH HYPERAMMONEMIA	0.00364964	0.36067029230417724
COG4-CDG	0.00364964	0.36067029230417724
COMPLEMENT HYPERACTIVATION, ANGIOPATHIC THROMBOSIS, AND PROTEIN-LOSING ENTEROPATHY; CHAPLE	0.00364964	0.36067029230417724
HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	0.00364964	0.36067029230417724
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.00364964	0.36067029230417724
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2	0.00364964	0.36067029230417724
FAMILIAL DYSAUTONOMIA	0.00364964	0.36067029230417724
HEREDITARY CENTRAL DIABETES INSIPIDUS	0.00364964	0.36067029230417724
DIARRHEA 2, WITH MICROVILLOUS ATROPHY	0.00364964	0.36067029230417724
SERKAL SYNDROME	0.00364964	0.36067029230417724
TORIELLO-LACASSIE-DROSTE SYNDROME	0.00364964	0.36067029230417724
OCULOCEREBRAL SYNDROME WITH HYPOPIGMENTATION	0.00364964	0.36067029230417724
ISOLATED OPTIC NERVE HYPOPLASIA/APLASIA	0.00364964	0.36067029230417724
LEBER CONGENITAL AMAUROSIS, TYPE I	0.00364964	0.36067029230417724
3MC SYNDROME 1	0.00364964	0.36067029230417724
OSTEODYSPLASTY, PRECOCIOUS, OF DANKS, MAYNE, AND KOZLOWSKI	0.00364964	0.36067029230417724
ZIMMERMANN-LABAND SYNDROME	0.00364964	0.36067029230417724
GALACTOSEMIA	0.00364964	0.36067029230417724
ACROCALLOSAL SYNDROME; ACLS	0.00364964	0.36067029230417724
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 3	0.00364964	0.36067029230417724
ALPHA-HEAVY CHAIN DISEASE	0.00364964	0.36067029230417724
SPASTIC ATAXIA 9, AUTOSOMAL RECESSIVE; SPAX9	0.00364964	0.36067029230417724
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.00364964	0.36067029230417724
NEPHROPATHIC INFANTILE CYSTINOSIS	0.00364964	0.36067029230417724
FAMILIAL HYPOALDOSTERONISM	0.00364964	0.36067029230417724
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.00364964	0.36067029230417724
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.00364964	0.36067029230417724
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.00364964	0.36067029230417724
DUPLICATION/INVERSION 15Q11	0.00364964	0.36067029230417724
CERNUNNOS-XLF DEFICIENCY	0.00364964	0.36067029230417724
GENERALIZED JUVENILE POLYPOSIS/JUVENILE POLYPOSIS COLI	0.00364964	0.36067029230417724
SUDDEN INFANT DEATH-DYSGENESIS OF THE TESTES SYNDROME	0.00364964	0.36067029230417724
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.00364964	0.36067029230417724
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.00364964	0.36067029230417724
2P21 MICRODELETION SYNDROME	0.00364964	0.36067029230417724
HYPOTONIA-CYSTINURIA SYNDROME	0.00364964	0.36067029230417724
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.00364964	0.36067029230417724
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.00364964	0.36067029230417724
2Q24 MICRODELETION SYNDROME	0.00364964	0.36067029230417724
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.00364964	0.36067029230417724
CRYPTOSPORIDIOSIS	0.00364964	0.36067029230417724
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.00364964	0.36067029230417724
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.00364964	0.36067029230417724
NATHALIE SYNDROME	0.00364964	0.36067029230417724
RING CHROMOSOME 22 SYNDROME	0.00364964	0.36067029230417724
NEPHRONOPHTHISIS 1	0.00364964	0.36067029230417724
RING CHROMOSOME 12 SYNDROME	0.00364964	0.36067029230417724
NEPHROTIC SYNDROME, TYPE 1; NPHS1	0.00364964	0.36067029230417724
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.00364964	0.36067029230417724
MICROPHTHALMIA, SYNDROMIC 1	0.00364964	0.36067029230417724
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.00364964	0.36067029230417724
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.00364964	0.36067029230417724
AXENFELD-RIEGER SYNDROME	0.00364964	0.36067029230417724
SECONDARY SHORT BOWEL SYNDROME	0.00364964	0.36067029230417724
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.00364964	0.36067029230417724
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6; CHNG6	0.00364964	0.36067029230417724
RENAL TUBULAR ACIDOSIS, PROXIMAL, WITH OCULAR ABNORMALITIES AND MENTALRETARDATION	0.00364964	0.36067029230417724
SALLA DISEASE	0.00364964	0.36067029230417724
JOUBERT SYNDROME 14	0.00364964	0.36067029230417724
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.00364964	0.36067029230417724
T-SUBSTANCE ANOMALY	0.00364964	0.36067029230417724
EPIDERMOLYSIS BULLOSA SIMPLEX, AUTOSOMAL RECESSIVE K14	0.00364964	0.36067029230417724
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24	0.00364964	0.36067029230417724
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 30	0.00364964	0.36067029230417724
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.00364964	0.36067029230417724
TYROSINE TRANSAMINASE DEFICIENCY	0.00364964	0.36067029230417724
GALACTOSE EPIMERASE DEFICIENCY	0.00364964	0.36067029230417724
BIOTINIDASE DEFICIENCY	0.00364964	0.36067029230417724
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.00364964	0.36067029230417724
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.00364964	0.36067029230417724
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.00364964	0.36067029230417724
THREONINEMIA	0.00364964	0.36067029230417724
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.00364964	0.36067029230417724
VAN MALDERGEM SYNDROME 1; VMLDS1	0.00364964	0.36067029230417724
ANTERIOR CHAMBER CLEAVAGE DISORDER, CEREBELLAR HYPOPLASIA, HYPOTHYROIDISM, AND TRACHEAL STENOSIS	0.00364964	0.36067029230417724
MONOSOMY 13Q34	0.00364964	0.36067029230417724
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.00364964	0.36067029230417724
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.00364964	0.36067029230417724
BARTH SYNDROME; BTHS	0.00364964	0.36067029230417724
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.00364964	0.36067029230417724
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13; COXPD13	0.00364964	0.36067029230417724
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1	0.00364964	0.36067029230417724
THYROID HEMIAGENESIS	0.00364964	0.36067029230417724
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.00364964	0.36067029230417724
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.00364964	0.36067029230417724
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.00364964	0.36067029230417724
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 4	0.00364964	0.36067029230417724
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.00364964	0.36067029230417724
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.00364964	0.36067029230417724
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 5	0.00364964	0.36067029230417724
CLASSIC PHENYLKETONURIA	0.00364964	0.36067029230417724
NEPHRONOPHTHISIS 4	0.00364964	0.36067029230417724
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.00364964	0.36067029230417724
CINCA SYNDROME; CINCA	0.00364964	0.36067029230417724
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.00364964	0.36067029230417724
DIAMOND-BLACKFAN ANEMIA 9	0.00364964	0.36067029230417724
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.00364964	0.36067029230417724
GLYCOGEN STORAGE DISEASE IXC	0.00364964	0.36067029230417724
MAJEED SYNDROME	0.00364964	0.36067029230417724
HARDIKAR SYNDROME	0.00364964	0.36067029230417724
AROMATASE DEFICIENCY	0.00364964	0.36067029230417724
DIAMOND-BLACKFAN ANEMIA 6; DBA6	0.00364964	0.36067029230417724
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.00364964	0.36067029230417724
MEHMO SYNDROME	0.00364964	0.36067029230417724
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.00364964	0.36067029230417724
FANCONI ANEMIA, COMPLEMENTATION GROUP B; FANCB	0.00364964	0.36067029230417724
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.00364964	0.36067029230417724
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.00364964	0.36067029230417724
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 9; MRT9	0.00364964	0.36067029230417724
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.00364964	0.36067029230417724
JUNCTIONAL EPIDERMOLYSIS BULLOSA, NON-HERLITZ TYPE	0.00364964	0.36067029230417724
ABLEPHARON MACROSTOMIA SYNDROME	0.00364964	0.36067029230417724
ACHALASIA-MICROCEPHALY SYNDROME	0.00364964	0.36067029230417724
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG	0.00364964	0.36067029230417724
WOLMAN DISEASE WITH HYPOLIPOPROTEINEMIA AND ACANTHOCYTOSIS	0.00364964	0.36067029230417724
JUNCTIONAL EPIDERMOLYSIS BULLOSA, GENERALIZED INTERMEDIATE	0.00364964	0.36067029230417724
LATHOSTEROLOSIS	0.00364964	0.36067029230417724
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA INVERSA	0.00364964	0.36067029230417724
MENTAL RETARDATION, X-LINKED 98; MRX98	0.00364964	0.36067029230417724
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.00364964	0.36067029230417724
ACETYL-COA CARBOXYLASE DEFICIENCY	0.00364964	0.36067029230417724
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.00364964	0.36067029230417724
CHROMOSOME 1P36 DELETION SYNDROME	0.00364964	0.36067029230417724
COLOBOMA, OCULAR	0.00364964	0.36067029230417724
JOUBERT SYNDROME 10	0.00364964	0.36067029230417724
EPIDERMOLYSIS BULLOSA SIMPLEX, DOWLING-MEARA TYPE; EBSDM	0.00364964	0.36067029230417724
HEREDITARY SPHEROCYTOSIS	0.00364964	0.36067029230417724
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.00364964	0.36067029230417724
NEPHRONOPHTHISIS 11; NPHP11	0.00364964	0.36067029230417724
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.00364964	0.36067029230417724
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.00364964	0.36067029230417724
RING CHROMOSOME 13 SYNDROME	0.00364964	0.36067029230417724
OSTEOPETROSIS,  AUTOSOMAL RECESSIVE 4; OPTB4	0.00364964	0.36067029230417724
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.00364964	0.36067029230417724
WOLMAN DISEASE	0.00364964	0.36067029230417724
LIG4 SYNDROME	0.00364964	0.36067029230417724
ADENYLOSUCCINASE DEFICIENCY	0.00364964	0.36067029230417724
IMMUNODEFICIENCY, COMMON VARIABLE, 11; CVID11	0.00364964	0.36067029230417724
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.00364964	0.36067029230417724
X SMALL RINGS	0.00364964	0.36067029230417724
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.00364964	0.36067029230417724
VAN MALDERGEM SYNDROME 2; VMLDS2	0.00364964	0.36067029230417724
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.00364964	0.36067029230417724
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.00364964	0.36067029230417724
CHROMOSOME 5Q12 DELETION SYNDROME	0.00364964	0.36067029230417724
CHYLOMICRON RETENTION DISEASE	0.00364964	0.36067029230417724
SCHIMKE X-LINKED MENTAL RETARDATION SYNDROME	0.00364964	0.36067029230417724
ERYTHRODERMA, CONGENITAL, WITH PALMOPLANTAR KERATODERMA, HYPOTRICHOSIS, AND HYPER-IGE; EPKHE	0.00364964	0.36067029230417724
OCULOECTODERMAL SYNDROME; OES	0.00364964	0.36067029230417724
GLYCOGEN STORAGE DISEASE IXA	0.00364964	0.36067029230417724
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.00364964	0.36067029230417724
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B	0.00364964	0.36067029230417724
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.00364964	0.36067029230417724
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.00364964	0.36067029230417724
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.00364964	0.36067029230417724
POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1	0.00364964	0.36067029230417724
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 2; AHMIO2	0.00364964	0.36067029230417724
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.00364964	0.36067029230417724
STING-ASSOCIATED VASCULOPATHY, INFANTILE-ONSET; SAVI	0.00364964	0.36067029230417724
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.00065189	0.0644220681629339
DDOST-CDG	0.00065189	0.0644220681629339
SAGLIKER SYNDROME	0.00065189	0.0644220681629339
MIRROR POLYDACTYLY-VERTEBRAL SEGMENTATION-LIMBS DEFECTS SYNDROME	0.00065189	0.0644220681629339
MARTSOLF SYNDROME	0.00065189	0.0644220681629339
COG5-CDG	0.00065189	0.0644220681629339
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.00065189	0.0644220681629339
2Q33.1 DELETION SYNDROME	0.00065189	0.0644220681629339
THANATOPHORIC DYSPLASIA TYPE 2	0.00065189	0.0644220681629339
118980 CLAVICLE, PSEUDARTHROSIS OF, CONGENITAL	0.00065189	0.0644220681629339
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.00065189	0.0644220681629339
OCULOAURICULOVERTEBRAL SPECTRUM WITH RADIAL DEFECTS	0.00065189	0.0644220681629339
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.00065189	0.0644220681629339
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.00065189	0.0644220681629339
CATARACT-ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.00065189	0.0644220681629339
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.00065189	0.0644220681629339
HYPOCALCEMIC VITAMIN D-RESISTANT RICKETS	0.00065189	0.0644220681629339
NEUTRAL LIPID STORAGE MYOPATHY	0.00065189	0.0644220681629339
FOUNTAIN SYNDROME	0.00065189	0.0644220681629339
115645 CATARACT, ABERRANT ORAL FRENULA, AND GROWTH RETARDATION	0.00065189	0.0644220681629339
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 4	0.00065189	0.0644220681629339
MOMO SYNDROME	0.00065189	0.0644220681629339
CRANIOFACIOFRONTODIGITAL SYNDROME	0.00065189	0.0644220681629339
AUTOSOMAL DOMINANT KENNY-CAFFEY SYNDROME	0.00065189	0.0644220681629339
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00065189	0.0644220681629339
15Q24 RECURRENT MICRODELETION SYNDROME	0.00065189	0.0644220681629339
SPONDYLOMETAPHYSEAL DYSPLASIA, SCHMIDT TYPE	0.00065189	0.0644220681629339
NEURALGIC AMYOTROPHY	0.00065189	0.0644220681629339
HEREDITARY ACROKERATOTIC POIKILODERMA	0.00065189	0.0644220681629339
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.00065189	0.0644220681629339
POSTAXIAL POLYDACTYLY-DENTAL AND VERTEBRAL ANOMALIES SYNDROME	0.00065189	0.0644220681629339
MAYER-ROKITANSKY-KÜSTER-HAUSER SYNDROME TYPE 2	0.00065189	0.0644220681629339
POLYNEUROPATHY-INTELLECTUAL DISABILITY-ACROMICRIA-PREMATURE MENOPAUSE SYNDROME	0.00065189	0.0644220681629339
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.00065189	0.0644220681629339
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.00065189	0.0644220681629339
MULIBREY NANISM	0.00065189	0.0644220681629339
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.00065189	0.0644220681629339
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.00065189	0.0644220681629339
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.00065189	0.0644220681629339
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.00065189	0.0644220681629339
DE BARSY SYNDROME	0.00065189	0.0644220681629339
PROGEROID SYNDROME, PETTY TYPE	0.00065189	0.0644220681629339
MOYNAHAN SYNDROME	0.00065189	0.0644220681629339
LEUKOCYTE ADHESION DEFICIENCY	0.00065189	0.0644220681629339
ACROOTOOCULAR SYNDROME	0.00065189	0.0644220681629339
PSEUDOPROGERIA SYNDROME	0.00065189	0.0644220681629339
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.00065189	0.0644220681629339
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.00065189	0.0644220681629339
SHORT STATURE-CRANIOFACIAL ANOMALIES-GENITAL HYPOPLASIA SYNDROME	0.00065189	0.0644220681629339
PAGOD SYNDROME	0.00065189	0.0644220681629339
AUTOSOMAL DOMINANT BRACHYOLMIA	0.00065189	0.0644220681629339
BRACHYOLMIA, MAROTEAUX TYPE	0.00065189	0.0644220681629339
ABRUZZO-ERICKSON SYNDROME	0.00065189	0.0644220681629339
212135 CARDIOSKELETAL SYNDROME, KUWAITI TYPE	0.00065189	0.0644220681629339
TEMPLE SYNDROME	0.00065189	0.0644220681629339
CLASSIC CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY	0.00065189	0.0644220681629339
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.00065189	0.0644220681629339
INTELLECTUAL DISABILITY-HYPOTONIA-BRACHYCEPHALY-PYLORIC STENOSIS-CRYPTORCHIDISM SYNDROME	0.00065189	0.0644220681629339
CONGENITAL ADRENAL HYPERPLASIA DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY	0.00065189	0.0644220681629339
CONGENITAL LIPOID ADRENAL HYPERPLASIA DUE TO STAR DEFICENCY	0.00065189	0.0644220681629339
WILLIAMS-BEUREN SYNDROME (WBS)	0.00065189	0.0644220681629339
DUPLICATION OF THE PITUITARY GLAND	0.00065189	0.0644220681629339
CEREBROFACIOARTICULAR SYNDROME	0.00065189	0.0644220681629339
C SYNDROME	0.00065189	0.0644220681629339
SHOX-RELATED SHORT STATURE	0.00065189	0.0644220681629339
COXOAURICULAR SYNDROME	0.00065189	0.0644220681629339
SHORT STATURE DUE TO PARTIAL GHR DEFICIENCY	0.00065189	0.0644220681629339
SHORT STATURE DUE TO GHSR DEFICIENCY	0.00065189	0.0644220681629339
SENIOR-LOKEN SYNDROME	0.00065189	0.0644220681629339
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.00065189	0.0644220681629339
WILLIAMS SYNDROME	0.00065189	0.0644220681629339
ERYTHROKERATODERMIA VARIABILIS	0.00065189	0.0644220681629339
CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	0.00065189	0.0644220681629339
WERNER SYNDROME	0.00065189	0.0644220681629339
MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY	0.00065189	0.0644220681629339
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY	0.00065189	0.0644220681629339
PRIMARY IMMUNODEFICIENCY SYNDROME DUE TO LAMTOR2 DEFICIENCY	0.00065189	0.0644220681629339
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.00065189	0.0644220681629339
X-LINKED HYPOPHOSPHATEMIA	0.00065189	0.0644220681629339
SUBAORTIC STENOSIS-SHORT STATURE SYNDROME	0.00065189	0.0644220681629339
BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM	0.00065189	0.0644220681629339
ERMINE PHENOTYPE	0.00065189	0.0644220681629339
CHONDROECTODERMAL DYSPLASIA WITH NIGHT BLINDNESS	0.00065189	0.0644220681629339
%211890 CAMPOMELIA, CUMMING TYPE;;CERVICAL LYMPHOCELE WITH BOWED LONG BONES;;CUMMING SYNDROME	0.00065189	0.0644220681629339
CONGENITAL ADRENAL HYPERPLASIA DUE TO 11-BETA-HYDROXYLASE DEFICIENCY	0.00065189	0.0644220681629339
MONOSOMY X	0.00065189	0.0644220681629339
XQ12-Q13.3 DUPLICATION SYNDROME	0.00065189	0.0644220681629339
INTELLECTUAL DISABILITY-MYOPATHY-SHORT STATURE-ENDOCRINE DEFECT SYNDROME	0.00065189	0.0644220681629339
COSTELLO SYNDROME	0.00065189	0.0644220681629339
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.00065189	0.0644220681629339
MOSAIC MONOSOMY X	0.00065189	0.0644220681629339
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.00065189	0.0644220681629339
INTELLECTUAL DISABILITY, BUENOS-AIRES TYPE	0.00065189	0.0644220681629339
MEVALONIC ACIDURIA	0.00065189	0.0644220681629339
CORNEODERMATOOSSEOUS SYNDROME	0.00065189	0.0644220681629339
RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY-DEAFNESS-HYPOGONADISM SYNDROME	0.00065189	0.0644220681629339
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.00065189	0.0644220681629339
GM2 GANGLIOSIDOSIS, AB VARIANT	0.00065189	0.0644220681629339
CORNELIA DE LANGE SYNDROME 1	0.00065189	0.0644220681629339
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.00065189	0.0644220681629339
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.00065189	0.0644220681629339
OXOGLUTARIC ACIDURIA	0.00065189	0.0644220681629339
RICHIERI COSTA-DA SILVA SYNDROME	0.00065189	0.0644220681629339
ZELLWEGER SYNDROME	0.00065189	0.0644220681629339
XERODERMA PIGMENTOSUM	0.00065189	0.0644220681629339
LAMELLAR ICHTHYOSIS	0.00065189	0.0644220681629339
CAT-EYE SYNDROME (TYPE I)	0.00065189	0.0644220681629339
SATOYOSHI SYNDROME	0.00065189	0.0644220681629339
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.00065189	0.0644220681629339
SAY-BARBER-MILLER SYNDROME	0.00065189	0.0644220681629339
PELIZAEUS-MERZBACHER DISEASE	0.00065189	0.0644220681629339
ULNAR-MAMMARY SYNDROME	0.00065189	0.0644220681629339
MICROCEPHALY-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00065189	0.0644220681629339
46,XY DISORDER OF SEX DEVELOPMENT DUE TO ISOLATED 17,20-LYASE DEFICIENCY	0.00065189	0.0644220681629339
CONGENITAL RUBELLA SYNDROME	0.00065189	0.0644220681629339
PELVISCAPULAR DYSPLASIA	0.00065189	0.0644220681629339
BRACHYDACTYLY, TYPE E, WITH ATRIAL SEPTAL DEFECT, TYPE II	0.00065189	0.0644220681629339
ADRENOMYODYSTROPHY	0.00065189	0.0644220681629339
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.00065189	0.0644220681629339
LYSINURIC PROTEIN INTOLERANCE; LPI	0.00065189	0.0644220681629339
EYE DEFECTS-ARACHNODACTYLY-CARDIOPATHY SYNDROME	0.00065189	0.0644220681629339
KLEEFSTRA SYNDROME	0.00065189	0.0644220681629339
THYROID ECTOPIA	0.00065189	0.0644220681629339
CONGENITAL ADRENAL HYPERPLASIA DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY	0.00065189	0.0644220681629339
XQ27.3Q28 DUPLICATION SYNDROME	0.00065189	0.0644220681629339
PITUITARY STALK INTERRUPTION SYNDROME	0.00065189	0.0644220681629339
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	0.00065189	0.0644220681629339
OROFACIODIGITAL SYNDROME TYPE 2	0.00065189	0.0644220681629339
SMITH-MAGENIS SYNDROME	0.00065189	0.0644220681629339
OROFACIODIGITAL SYNDROME TYPE 6	0.00065189	0.0644220681629339
AURICULOOSTEODYSPLASIA	0.00065189	0.0644220681629339
ACROCRANIOFACIAL DYSOSTOSIS	0.00065189	0.0644220681629339
ATHYREOSIS	0.00065189	0.0644220681629339
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.00065189	0.0644220681629339
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.00065189	0.0644220681629339
COLE-CARPENTER SYNDROME 1; CLCRP1	0.00065189	0.0644220681629339
OSLAM SYNDROME	0.00065189	0.0644220681629339
DEAFNESS, CONGENITAL, WITH VITILIGO AND ACHALASIA	0.00065189	0.0644220681629339
CYSTINOSIS, NEPHROPATHIC; CTNS	0.00065189	0.0644220681629339
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.00065189	0.0644220681629339
BRUCK SYNDROME	0.00065189	0.0644220681629339
15Q13.3 MICRODELETION SYNDROME	0.00065189	0.0644220681629339
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.00065189	0.0644220681629339
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.00065189	0.0644220681629339
15Q24 MICRODELETION SYNDROME	0.00065189	0.0644220681629339
SMITH-FINEMAN-MYERS SYNDROME	0.00065189	0.0644220681629339
SEVERE OCULO-RENAL-CEREBELLAR SYNDROME	0.00065189	0.0644220681629339
ANGEL-SHAPED PHALANGOEPIPHYSEAL DYSPLASIA	0.00065189	0.0644220681629339
MICROTRIPLICATION 11Q24.1	0.00065189	0.0644220681629339
KEIPERT SYNDROME	0.00065189	0.0644220681629339
EPIPHYSEAL DYSPLASIA, MICROCEPHALY, AND NYSTAGMUS	0.00065189	0.0644220681629339
KOOLEN-DE VRIES SYNDROME	0.00065189	0.0644220681629339
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.00065189	0.0644220681629339
FIBULAR APLASIA-COMPLEX BRACHYDACTYLY SYNDROME	0.00065189	0.0644220681629339
14Q22Q23 MICRODELETION SYNDROME	0.00065189	0.0644220681629339
DISTAL MONOSOMY 12Q	0.00065189	0.0644220681629339
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.00065189	0.0644220681629339
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 4	0.00065189	0.0644220681629339
DISTAL MONOSOMY 10Q	0.00065189	0.0644220681629339
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.00065189	0.0644220681629339
FANCONI ANEMIA	0.00065189	0.0644220681629339
7Q11.23 MICRODUPLICATION SYNDROME	0.00065189	0.0644220681629339
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.00065189	0.0644220681629339
DISTAL TRISOMY 5Q	0.00065189	0.0644220681629339
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00065189	0.0644220681629339
MOSAIC TRISOMY 8	0.00065189	0.0644220681629339
NATHALIE SYNDROME	0.00065189	0.0644220681629339
DIAMOND-BLACKFAN ANEMIA 1	0.00065189	0.0644220681629339
FIBULAR APLASIA OR HYPOPLASIA, FEMORAL BOWING AND POLY-, SYN-, AND OLIGODACTYLY	0.00065189	0.0644220681629339
THYROID HYPOPLASIA	0.00065189	0.0644220681629339
BRACHYDACTYLOUS DWARFISM, MSELENI TYPE	0.00065189	0.0644220681629339
3M SYNDROME	0.00065189	0.0644220681629339
RING CHROMOSOME Y SYNDROME	0.00065189	0.0644220681629339
NEUROFACIODIGITORENAL SYNDROME	0.00065189	0.0644220681629339
FAMILIAL THYROID DYSHORMONOGENESIS	0.00065189	0.0644220681629339
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.00065189	0.0644220681629339
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.00065189	0.0644220681629339
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR	0.00065189	0.0644220681629339
21Q22.11Q22.12 MICRODELETION SYNDROME	0.00065189	0.0644220681629339
CARPENTER-WAZIRI SYNDROME	0.00065189	0.0644220681629339
JUBERG-MARSIDI SYNDROME	0.00065189	0.0644220681629339
16P11.2P12.2 MICRODELETION SYNDROME	0.00065189	0.0644220681629339
16P13.11 MICRODELETION SYNDROME	0.00065189	0.0644220681629339
XP22.13P22.2 DUPLICATION SYNDROME	0.00065189	0.0644220681629339
BRACHYDACTYLY TYPE C	0.00065189	0.0644220681629339
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.00065189	0.0644220681629339
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.00065189	0.0644220681629339
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.00065189	0.0644220681629339
COSTELLO SYNDROME; CSTLO	0.00065189	0.0644220681629339
SPINOCEREBELLAR ATAXIA TYPE 13	0.00065189	0.0644220681629339
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.00065189	0.0644220681629339
COHEN SYNDROME	0.00065189	0.0644220681629339
SHORT STATURE-WORMIAN BONES-DEXTROCARDIA SYNDROME	0.00065189	0.0644220681629339
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MISSOURI TYPE	0.00065189	0.0644220681629339
SHORT STATURE-WEBBED NECK-HEART DISEASE SYNDROME	0.00065189	0.0644220681629339
SHORT STATURE, BRUSSELS TYPE	0.00065189	0.0644220681629339
AUTOSOMAL RECESSIVE DISTAL OSTEOLYSIS SYNDROME	0.00065189	0.0644220681629339
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.00065189	0.0644220681629339
15Q14 MICRODELETION SYNDROME	0.00065189	0.0644220681629339
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.00065189	0.0644220681629339
PFEIFFER-PALM-TELLER SYNDROME	0.00065189	0.0644220681629339
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.00065189	0.0644220681629339
TIBIAL HEMIMELIA-POLYSYNDACTYLY-TRIPHALANGEAL THUMB SYNDROME	0.00065189	0.0644220681629339
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.00065189	0.0644220681629339
EPIPHYSEAL DYSPLASIA, MULTIPLE, 4	0.00065189	0.0644220681629339
BRACHYDACTYLY, TYPE A6	0.00065189	0.0644220681629339
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.00065189	0.0644220681629339
AUTOSOMAL RECESSIVE HYPOPHOSPHATEMIC RICKETS	0.00065189	0.0644220681629339
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.00065189	0.0644220681629339
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.00065189	0.0644220681629339
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.00065189	0.0644220681629339
17Q12 MICRODELETION SYNDROME	0.00065189	0.0644220681629339
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.00065189	0.0644220681629339
BRACHYDACTYLY TYPE E	0.00065189	0.0644220681629339
CHUDLEY-LOWRY-HOAR SYNDROME	0.00065189	0.0644220681629339
HOLMES-GANG SYNDROME	0.00065189	0.0644220681629339
OSTEOPOROSIS-OCULOCUTANEOUS HYPOPIGMENTATION SYNDROME	0.00065189	0.0644220681629339
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.00065189	0.0644220681629339
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.00065189	0.0644220681629339
OTOFACIOCERVICAL SYNDROME	0.00065189	0.0644220681629339
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.00065189	0.0644220681629339
JUVENILE PAGET DISEASE	0.00065189	0.0644220681629339
CROME SYNDROME	0.00065189	0.0644220681629339
FG SYNDROME TYPE 1	0.00065189	0.0644220681629339
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.00065189	0.0644220681629339
HURLER-SCHEIE SYNDROME	0.00065189	0.0644220681629339
HURLER SYNDROME	0.00065189	0.0644220681629339
MONOSOMY 5P	0.00065189	0.0644220681629339
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.00065189	0.0644220681629339
MULTIPLE METAPHYSEAL DYSPLASIA	0.00065189	0.0644220681629339
NAIL-PATELLA-LIKE RENAL DISEASE	0.00065189	0.0644220681629339
22Q11.2 DISTAL DELETION SYNDROME	0.00065189	0.0644220681629339
PARANA HARD SKIN SYNDROME	0.00065189	0.0644220681629339
SPASTIC PARAPARESIS-DEAFNESS SYNDROME	0.00065189	0.0644220681629339
20P12.3 MICRODELETION SYNDROME	0.00065189	0.0644220681629339
BRACHYDACTYLY TYPE A4	0.00065189	0.0644220681629339
BRACHYDACTYLY TYPE A1	0.00065189	0.0644220681629339
STIFF SKIN SYNDROME	0.00065189	0.0644220681629339
WRINKLY SKIN SYNDROME	0.00065189	0.0644220681629339
TRISOMY 17P	0.00065189	0.0644220681629339
17Q23.1Q23.2 MICRODELETION SYNDROME	0.00065189	0.0644220681629339
HYALURONIDASE DEFICIENCY	0.00065189	0.0644220681629339
BIEMOND SYNDROME II	0.00065189	0.0644220681629339
WAGR SYNDROME	0.00065189	0.0644220681629339
KID SYNDROME	0.00065189	0.0644220681629339
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.00065189	0.0644220681629339
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.00065189	0.0644220681629339
SIX2-RELATED FRONTONASAL DYSPLASIA	0.00065189	0.0644220681629339
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A	0.00065189	0.0644220681629339
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.00065189	0.0644220681629339
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.00065189	0.0644220681629339
JEUNE SYNDROME	0.00065189	0.0644220681629339
NIEMANN-PICK DISEASE TYPE B	0.00065189	0.0644220681629339
AROMATASE EXCESS SYNDROME	0.00065189	0.0644220681629339
RETT SYNDROME	0.00065189	0.0644220681629339
X-LINKED AGAMMAGLOBULINEMIA	0.00065189	0.0644220681629339
RADIAL-RENAL SYNDROME	0.00065189	0.0644220681629339
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.00065189	0.0644220681629339
RUBINSTEIN-TAYBI SYNDROME	0.00065189	0.0644220681629339
MICROCEPHALY-MICROCORNEA SYNDROME, SEEMANOVA TYPE	0.00065189	0.0644220681629339
PRADER-WILLI SYNDROME; PWS	0.00065189	0.0644220681629339
EIKEN SYNDROME	0.00065189	0.0644220681629339
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.00065189	0.0644220681629339
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.00065189	0.0644220681629339
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.00065189	0.0644220681629339
RABSON-MENDENHALL SYNDROME	0.00065189	0.0644220681629339
LEPRECHAUNISM	0.00065189	0.0644220681629339
HAIRY ELBOWS	0.00065189	0.0644220681629339
PELVIS-SHOULDER DYSPLASIA	0.00065189	0.0644220681629339
LARSEN SYNDROME	0.00065189	0.0644220681629339
TRICHORHINOPHALANGEAL SYNDROME TYPE 1 AND 3	0.00065189	0.0644220681629339
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.00065189	0.0644220681629339
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.00065189	0.0644220681629339
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.00065189	0.0644220681629339
PHOCOMELIA-ECTRODACTYLY, EAR MALFORMATION, DEAFNESS, AND SINUS ARRHYTHMIA	0.00065189	0.0644220681629339
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.00065189	0.0644220681629339
INFANTILE REFSUM DISEASE	0.00065189	0.0644220681629339
JUVENILE POLYPOSIS OF INFANCY	0.00065189	0.0644220681629339
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.00065189	0.0644220681629339
BRANCHIOGENIC DEAFNESS SYNDROME	0.00065189	0.0644220681629339
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.00065189	0.0644220681629339
ISOLATED SEDOHEPTULOKINASE DEFICIENCY	0.00065189	0.0644220681629339
SEPTOOPTIC DYSPLASIA	0.00065189	0.0644220681629339
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.00065189	0.0644220681629339
NEONATAL ADRENOLEUKODYSTROPHY	0.00065189	0.0644220681629339
SKELETAL DYSPLASIA WITH DELAYED EPIPHYSEAL AND CARPAL BONE OSSIFICATION	0.00065189	0.0644220681629339
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.00065189	0.0644220681629339
HYPOPHOSPHATEMIC RICKETS	0.00065189	0.0644220681629339
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.00065189	0.0644220681629339
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.00065189	0.0644220681629339
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.00065189	0.0644220681629339
FLOATING-HARBOR SYNDROME	0.00065189	0.0644220681629339
CATARACT-GROWTH HORMONE DEFICIENCY-SENSORY NEUROPATHY-SENSORINEURAL HEARING LOSS-SKELETAL DYSPLASIA SYNDROME	0.00065189	0.0644220681629339
INTRAUTERINE GROWTH RESTRICTION-SHORT STATURE-EARLY ADULT-ONSET DIABETES SYNDROME	0.00065189	0.0644220681629339
HYPOPHOSPHATASIA	0.00065189	0.0644220681629339
CONGENITAL HYPOTHYROIDISM	0.00065189	0.0644220681629339
SHPRINTZEN OMPHALOCELE SYNDROME	0.00065189	0.0644220681629339
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.00065189	0.0644220681629339
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.00065189	0.0644220681629339
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.00065189	0.0644220681629339
INCONTINENTIA PIGMENTI	0.00065189	0.0644220681629339
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.00065189	0.0644220681629339
179830 RENAL TUBULAR ACIDOSIS, PROXIMAL;;RENAL TUBULAR ACIDOSIS II;;RTA, PROXIMAL TYPE;;RTA, RATE TYPE	0.00065189	0.0644220681629339
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.00065189	0.0644220681629339
INTELLECTUAL DISABILITY-MUSCLE WEAKNESS-SHORT STATURE-FACIAL DYSMORPHISM SYNDROME	0.00065189	0.0644220681629339
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.00065189	0.0644220681629339
SCHIZOPHRENIA 1; SCZD1	0.00065189	0.0644220681629339
AUTOSOMAL DOMINANT MITOCHONDRIAL MYOPATHY WITH EXERCISE INTOLERANCE	0.00065189	0.0644220681629339
RUVALCABA SYNDROME	0.00065189	0.0644220681629339
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.00065189	0.0644220681629339
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.00065189	0.0644220681629339
JUVENILE-ONSET DIABETES MELLITUS-CENTRAL AND PERIPHERAL NEURODEGENERATION SYNDROME	0.00065189	0.0644220681629339
SAY SYNDROME	0.00065189	0.0644220681629339
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00065189	0.0644220681629339
PYCNODYSOSTOSIS	0.00065189	0.0644220681629339
211120 BONE DYSPLASIA, LETHAL, HOLMGREN TYPE	0.00065189	0.0644220681629339
DENTINOGENESIS IMPERFECTA-SHORT STATURE-HEARING LOSS-INTELLECTUAL DISABILITY SYNDROME	0.00065189	0.0644220681629339
ANGEL-SHAPED PHALANGO-EPIPHYSEAL DYSPLASIA	0.00065189	0.0644220681629339
CHROMOSOME 8Q22.1 DUPLICATION SYNDROME	0.00065189	0.0644220681629339
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.00065189	0.0644220681629339
NON-ACQUIRED ISOLATED GROWTH HORMONE DEFICIENCY	0.00065189	0.0644220681629339
PFEIFFER SYNDROME	0.00065189	0.0644220681629339
CHROMOSOME 18P DELETION SYNDROME	0.00065189	0.0644220681629339
HYPOPHOSPHATEMIC BONE DISEASE	0.00065189	0.0644220681629339
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00065189	0.0644220681629339
MULTIMINICORE MYOPATHY	0.00065189	0.0644220681629339
MULTIPLE SULFATASE DEFICIENCY	0.00065189	0.0644220681629339
METAPHYSEAL DYSPLASIA WITH MAXILLARY HYPOPLASIA AND BRACHYDACTYLY	0.00065189	0.0644220681629339
MUCOPOLYSACCHARIDOSIS TYPE 4	0.00065189	0.0644220681629339
MUCOPOLYSACCHARIDOSIS TYPE 2	0.00065189	0.0644220681629339
MUCOPOLYSACCHARIDOSIS TYPE 1	0.00065189	0.0644220681629339
ACROCAPITOFEMORAL DYSPLASIA	0.00065189	0.0644220681629339
LEGG-CALVE-PERTHES DISEASE	0.00065189	0.0644220681629339
MUCOLIPIDOSIS TYPE II	0.00065189	0.0644220681629339
KABUKI SYNDROME 1	0.00065189	0.0644220681629339
DYSOSTOSIS WITH BRACHYDACTYLY	0.00065189	0.0644220681629339
ISCHIOCOXOPODOPATELLAR SYNDROME WITH OR WITHOUT PULMONARY ARTERIAL HYPERTENSION	0.00065189	0.0644220681629339
CEDNIK SYNDROME	0.00065189	0.0644220681629339
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.00065189	0.0644220681629339
OSTEOGENESIS IMPERFECTA	0.00065189	0.0644220681629339
SHORT FIFTH METACARPALS-INSULIN RESISTANCE SYNDROME	0.00065189	0.0644220681629339
3C SYNDROME	0.00065189	0.0644220681629339
NEUROFIBROMATOSIS-NOONAN SYNDROME	0.00065189	0.0644220681629339
SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR; SMMCI	0.00065189	0.0644220681629339
HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA	0.00065189	0.0644220681629339
NOONAN SYNDROME	0.00065189	0.0644220681629339
NIJMEGEN BREAKAGE SYNDROME	0.00065189	0.0644220681629339
PALLISTER-HALL SYNDROME	0.00065189	0.0644220681629339
KBG SYNDROME	0.00065189	0.0644220681629339
MUCOLIPIDOSIS TYPE III	0.00065189	0.0644220681629339
MUCKLE-WELLS SYNDROME	0.00065189	0.0644220681629339
OSTEOGENESIS IMPERFECTA, TYPE IV	0.00065189	0.0644220681629339
NEUROFIBROMATOSIS, TYPE I	0.00065189	0.0644220681629339
NAIL-PATELLA SYNDROME	0.00065189	0.0644220681629339
XQ25 MICRODUPLICATION SYNDROME	0.00065189	0.0644220681629339
ULNAR/FIBULA RAY DEFECT-BRACHYDACTYLY SYNDROME	0.00065189	0.0644220681629339
CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY-COLOBOMA-MICROGNATHIA SYNDROME	0.00065189	0.0644220681629339
BRADDOCK SYNDROME	0.00065189	0.0644220681629339
PERIODONTAL EHLERS-DANLOS SYNDROME	0.00065189	0.0644220681629339
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.00065189	0.0644220681629339
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.00065189	0.0644220681629339
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.00065189	0.0644220681629339
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00065189	0.0644220681629339
X-LINKED EHLERS-DANLOS SYNDROME	0.00065189	0.0644220681629339
PSEUDOHYPOALDOSTERONISM TYPE 2	0.00065189	0.0644220681629339
139750 HAND AND FOOT DEFORMITY WITH FLAT FACIES	0.00065189	0.0644220681629339
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.00065189	0.0644220681629339
INCLUSION BODY MYOPATHY WITH PAGET DISEASE OF BONE AND FRONTOTEMPORAL DEMENTIA	0.00065189	0.0644220681629339
ALBERS-SCHÖNBERG OSTEOPETROSIS	0.00065189	0.0644220681629339
MICROPHTHALMIA, LENZ TYPE	0.00065189	0.0644220681629339
MERRF	0.00065189	0.0644220681629339
HYPERTELORISM, TEEBI TYPE; TBHS	0.00065189	0.0644220681629339
MICROCEPHALY, AUTOSOMAL DOMINANT	0.00065189	0.0644220681629339
MARSHALL SYNDROME	0.00065189	0.0644220681629339
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.00065189	0.0644220681629339
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR I RESISTANCE	0.00065189	0.0644220681629339
PRADER-WILLI SYNDROME	0.00065189	0.0644220681629339
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.00065189	0.0644220681629339
BRAIN MALFORMATION-CONGENITAL HEART DISEASE-POSTAXIAL POLYDACTYLY SYNDROME	0.00065189	0.0644220681629339
ARTHROGRYPOSIS, DISTAL, TYPE 7	0.00065189	0.0644220681629339
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.00065189	0.0644220681629339
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.00065189	0.0644220681629339
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.00065189	0.0644220681629339
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.00065189	0.0644220681629339
OCULOCEREBRORENAL SYNDROME OF LOWE	0.00065189	0.0644220681629339
184000 SPONDYLOEPIPHYSEAL DYSPLASIA, MYOPIA, AND SENSORINEURAL DEAFNESS	0.00065189	0.0644220681629339
SPONDYLOMETAPHYSEAL DYSPLASIA, CORNER FRACTURE TYPE; SMDCF	0.00065189	0.0644220681629339
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.00065189	0.0644220681629339
THALIDOMIDE EMBRYOPATHY	0.00065189	0.0644220681629339
FARBER DISEASE	0.00065189	0.0644220681629339
MICROCEPHALIC OSTEODYSPLASTIC DYSPLASIA, SAUL-WILSON TYPE	0.00065189	0.0644220681629339
HOYERAAL-HREIDARSSON SYNDROME	0.00065189	0.0644220681629339
EHLERS-DANLOS SYNDROME, VASCULAR TYPE; EDSVASC	0.00065189	0.0644220681629339
EHLERS-DANLOS SYNDROME, TYPE I	0.00065189	0.0644220681629339
CONGENITAL AMEGAKARYOCYTIC THROMBOCYTOPENIA	0.00065189	0.0644220681629339
DYSSPONDYLOENCHONDROMATOSIS	0.00065189	0.0644220681629339
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.00065189	0.0644220681629339
GENITOPATELLAR SYNDROME	0.00065189	0.0644220681629339
KEUTEL SYNDROME	0.00065189	0.0644220681629339
X-LINKED INTELLECTUAL DISABILITY, ABIDI TYPE	0.00065189	0.0644220681629339
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY 7	0.00065189	0.0644220681629339
MICROPHTHALMIA, SYNDROMIC 3	0.00065189	0.0644220681629339
ARTERIOSCLEROSIS, SEVERE JUVENILE	0.00065189	0.0644220681629339
HYPOPLASTIC TIBIAE-POSTAXIAL POLYDACTYLY SYNDROME	0.00065189	0.0644220681629339
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.00065189	0.0644220681629339
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.00065189	0.0644220681629339
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASEDEFICIENCY	0.00065189	0.0644220681629339
WEILL-MARCHESANI SYNDROME	0.00065189	0.0644220681629339
VOGT-KOYANAGI-HARADA DISEASE	0.00065189	0.0644220681629339
MICROCEPHALY-BRACHYDACTYLY-KYPHOSCOLIOSIS SYNDROME	0.00065189	0.0644220681629339
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.00065189	0.0644220681629339
DOUBLE OUTLET RIGHT VENTRICLE	0.00065189	0.0644220681629339
VELO-FACIAL-SKELETAL SYNDROME	0.00065189	0.0644220681629339
URBAN-ROGERS-MEYER SYNDROME	0.00065189	0.0644220681629339
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.00065189	0.0644220681629339
FANCONI ANEMIA	0.00065189	0.0644220681629339
SYNDROMIC DIARRHEA	0.00065189	0.0644220681629339
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.00065189	0.0644220681629339
TRISOMY 18	0.00065189	0.0644220681629339
LATERAL MENINGOCELE SYNDROME	0.00065189	0.0644220681629339
TRISMUS-PSEUDOCAMPTODACTYLY SYNDROME	0.00065189	0.0644220681629339
SEVERE EARLY-ONSET OBESITY-INSULIN RESISTANCE SYNDROME DUE TO SH2B1 DEFICIENCY	0.00065189	0.0644220681629339
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.00065189	0.0644220681629339
TEMPLE-BARAITSER SYNDROME	0.00065189	0.0644220681629339
TETRASOMY 12P	0.00065189	0.0644220681629339
TOWNES-BROCKS SYNDROME	0.00065189	0.0644220681629339
TRIPLE A SYNDROME	0.00065189	0.0644220681629339
WHITE MATTER HYPOPLASIA-CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY SYNDROME	0.00065189	0.0644220681629339
SIALIDOSIS TYPE 2	0.00065189	0.0644220681629339
TURNER SYNDROME	0.00065189	0.0644220681629339
STORMORKEN-SJAASTAD-LANGSLET SYNDROME	0.00065189	0.0644220681629339
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.00065189	0.0644220681629339
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.00065189	0.0644220681629339
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.00065189	0.0644220681629339
VENTRICULAR EXTRASYSTOLES WITH SYNCOPAL EPISODES-PERODACTYLY-ROBIN SEQUENCE SYNDROME	0.00065189	0.0644220681629339
APPARENT MINERALOCORTICOID EXCESS	0.00065189	0.0644220681629339
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.00065189	0.0644220681629339
STIMMLER SYNDROME	0.00065189	0.0644220681629339
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.00065189	0.0644220681629339
MULTIPLE OSTEOCHONDROMAS	0.00065189	0.0644220681629339
FOUNTAIN SYNDROME	0.00065189	0.0644220681629339
ASPARTYLGLUCOSAMINURIA; AGU	0.00065189	0.0644220681629339
PALLISTER-HALL SYNDROME	0.00065189	0.0644220681629339
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.00065189	0.0644220681629339
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.00065189	0.0644220681629339
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.00065189	0.0644220681629339
SHORT-RIB THORACIC DYSPLASIA 1 WITH OR WITHOUT POLYDACTYLY; SRTD1	0.00065189	0.0644220681629339
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.00065189	0.0644220681629339
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.00065189	0.0644220681629339
CLASSIC MULTIMINICORE MYOPATHY	0.00065189	0.0644220681629339
DEAFNESS-ENAMEL HYPOPLASIA-NAIL DEFECTS SYNDROME	0.00065189	0.0644220681629339
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.00065189	0.0644220681629339
9P13 MICRODELETION SYNDROME	0.00065189	0.0644220681629339
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.00065189	0.0644220681629339
X-LINKED INTELLECTUAL DISABILITY, SHRIMPTON TYPE	0.00065189	0.0644220681629339
X-LINKED INTELLECTUAL DISABILITY, STOLL TYPE	0.00065189	0.0644220681629339
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.00065189	0.0644220681629339
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.00065189	0.0644220681629339
WILSON-TURNER SYNDROME	0.00065189	0.0644220681629339
YUNIS-VARON SYNDROME	0.00065189	0.0644220681629339
ATYPICAL WERNER SYNDROME	0.00065189	0.0644220681629339
FANCONI RENOTUBULAR SYNDROME 1; FRTS1	0.00065189	0.0644220681629339
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.00065189	0.0644220681629339
TRICHORHINOPHALANGEAL SYNDROME, TYPE I	0.00065189	0.0644220681629339
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.00065189	0.0644220681629339
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.00065189	0.0644220681629339
TRIPHALANGEAL THUMBS AND DISLOCATION OF PATELLA	0.00065189	0.0644220681629339
AUTOIMMUNE ENTEROPATHY AND ENDOCRINOPATHY-SUSCEPTIBILITY TO CHRONIC INFECTIONS SYNDROME	0.00065189	0.0644220681629339
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.00065189	0.0644220681629339
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.00065189	0.0644220681629339
VELOCARDIOFACIAL SYNDROME	0.00065189	0.0644220681629339
HIRSCHSPRUNG DISEASE	0.00065189	0.0644220681629339
133750 EXTRASYSTOLES, MULTIFORM VENTRICULAR, WITH SHORT STATURE, HYPERPIGMENTATIONAND MICROCEPHALY	0.00065189	0.0644220681629339
GRISCELLI SYNDROME	0.00065189	0.0644220681629339
EXOSTOSES, MULTIPLE, TYPE II	0.00065189	0.0644220681629339
CONGENITAL NON-BULLOUS ICHTHYOSIFORM ERYTHRODERMA	0.00065189	0.0644220681629339
PRADER-WILLI-LIKE SYNDROME	0.00065189	0.0644220681629339
STICKLER SYNDROME	0.00065189	0.0644220681629339
COFFIN-SIRIS SYNDROME 1; CSS1	0.00065189	0.0644220681629339
STIFF SKIN SYNDROME	0.00065189	0.0644220681629339
NEONATAL SEVERE PRIMARY HYPERPARATHYROIDISM	0.00065189	0.0644220681629339
13Q12.3 MICRODELETION SYNDROME	0.00065189	0.0644220681629339
ISOLATED GLYCEROL KINASE DEFICIENCY	0.00065189	0.0644220681629339
FINGER LOCKING, RECURRENT, WITH INTRAUTERINE GROWTH RETARDATION ANDPROPORTIONATE SHORT STATURE	0.00065189	0.0644220681629339
ADNP SYNDROME	0.00065189	0.0644220681629339
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.00065189	0.0644220681629339
DIGEORGE SYNDROME; DGS	0.00065189	0.0644220681629339
MEND SYNDROME	0.00065189	0.0644220681629339
THORACOPELVIC DYSOSTOSIS	0.00065189	0.0644220681629339
9Q31.1Q31.3 MICRODELETION SYNDROME	0.00065189	0.0644220681629339
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 63	0.00065189	0.0644220681629339
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.00065189	0.0644220681629339
THUMB DEFORMITY AND ALOPECIA	0.00065189	0.0644220681629339
SECKEL SYNDROME	0.00065189	0.0644220681629339
GORDON SYNDROME	0.00065189	0.0644220681629339
SHWACHMAN-DIAMOND SYNDROME	0.00065189	0.0644220681629339
ACROCRANIOFACIAL DYSOSTOSIS	0.00065189	0.0644220681629339
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.00065189	0.0644220681629339
WILLIAMS-BEUREN SYNDROME; WBS	0.00065189	0.0644220681629339
SJÖGREN-LARSSON SYNDROME	0.00065189	0.0644220681629339
EXOSTOSES, MULTIPLE, TYPE I	0.00065189	0.0644220681629339
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.00065189	0.0644220681629339
SMITH-MAGENIS SYNDROME	0.00065189	0.0644220681629339
GAUCHER DISEASE	0.00065189	0.0644220681629339
GOLDENHAR SYNDROME	0.00065189	0.0644220681629339
GM1 GANGLIOSIDOSIS	0.00065189	0.0644220681629339
ROIFMAN SYNDROME	0.00065189	0.0644220681629339
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.00065189	0.0644220681629339
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	0.00065189	0.0644220681629339
ISOLATED SPINA BIFIDA	0.00065189	0.0644220681629339
ACROFACIAL DYSOSTOSIS SYNDROME OF RODRIGUEZ	0.00065189	0.0644220681629339
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.00065189	0.0644220681629339
DISTAL MONOSOMY 1Q	0.00065189	0.0644220681629339
WATSON SYNDROME	0.00065189	0.0644220681629339
SILVER-RUSSELL SYNDROME	0.00065189	0.0644220681629339
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.00065189	0.0644220681629339
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.00065189	0.0644220681629339
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL DOMINANT	0.00065189	0.0644220681629339
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN DEBRANCHING ENZYME DEFICIENCY	0.00065189	0.0644220681629339
GLYCOGEN STORAGE DISEASE DUE TO LIVER GLYCOGEN PHOSPHORYLASE DEFICIENCY	0.00065189	0.0644220681629339
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.00065189	0.0644220681629339
ACRODERMATITIS ENTEROPATHICA	0.00065189	0.0644220681629339
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHORYLASE KINASE DEFICIENCY	0.00065189	0.0644220681629339
SIALIDOSIS TYPE 1	0.00065189	0.0644220681629339
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	0.00065189	0.0644220681629339
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.00065189	0.0644220681629339
XYLT1-CDG	0.00065189	0.0644220681629339
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.00065189	0.0644220681629339
PRECOCIOUS PUBERTY, CENTRAL	0.00065189	0.0644220681629339
DYSPLASTIC CORTICAL HYPEROSTOSIS	0.00065189	0.0644220681629339
MICROCEPHALY-CERVICAL SPINE FUSION ANOMALIES SYNDROME	0.00065189	0.0644220681629339
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.00065189	0.0644220681629339
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.00065189	0.0644220681629339
NOONAN SYNDROME 8; NS8	0.00065189	0.0644220681629339
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.00065189	0.0644220681629339
FANCONI ANEMIA, COMPLEMENTATION GROUP Q; FANCQ	0.00065189	0.0644220681629339
THUMB AGENESIS, SHORT STATURE, AND IMMUNODEFICIENCY	0.00065189	0.0644220681629339
STEEL SYNDROME; STLS	0.00065189	0.0644220681629339
TYSHCHENKO SYNDROME	0.00065189	0.0644220681629339
ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D	0.00065189	0.0644220681629339
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.00065189	0.0644220681629339
LEPTIN RECEPTOR DEFICIENCY; LEPRD	0.00065189	0.0644220681629339
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.00065189	0.0644220681629339
DIAMOND-BLACKFAN ANEMIA 11; DBA11	0.00065189	0.0644220681629339
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.00065189	0.0644220681629339
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.00065189	0.0644220681629339
WEILL-MARCHESANI SYNDROME 3	0.00065189	0.0644220681629339
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.00065189	0.0644220681629339
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.00065189	0.0644220681629339
THYROTROPIN-RELEASING HORMONE DEFICIENCY	0.00065189	0.0644220681629339
COFFIN-SIRIS SYNDROME 4; CSS4	0.00065189	0.0644220681629339
COFFIN-SIRIS SYNDROME 3; CSS3	0.00065189	0.0644220681629339
COFFIN-SIRIS SYNDROME 2; CSS2	0.00065189	0.0644220681629339
TEEBI-SHALTOUT SYNDROME; TBSH	0.00065189	0.0644220681629339
SCHAAF-YANG SYNDROME; SHFYNG	0.00065189	0.0644220681629339
CHROMOSOME 17Q12 DELETION SYNDROME	0.00065189	0.0644220681629339
LOEYS-DIETZ SYNDROME 5	0.00065189	0.0644220681629339
AUTOINFLAMMATION WITH INFANTILE ENTEROCOLITIS; AIFEC	0.00065189	0.0644220681629339
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL RECESSIVE	0.00065189	0.0644220681629339
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.00065189	0.0644220681629339
FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG; FRTS4	0.00065189	0.0644220681629339
NEUTROPENIA, SEVERE CONGENITAL, 6, AUTOSOMAL RECESSIVE; SCN6	0.00065189	0.0644220681629339
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.00065189	0.0644220681629339
IMMUNODEFICIENCY 36; IMD36	0.00065189	0.0644220681629339
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1; ADMIO1	0.00065189	0.0644220681629339
GROWTH HORMONE DEFICIENCY, ISOLATED PARTIAL; GHDP	0.00065189	0.0644220681629339
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.00065189	0.0644220681629339
SPONDYLOPERIPHERAL DYSPLASIA	0.00065189	0.0644220681629339
HELSMOORTEL-VAN DER AA SYNDROME	0.00065189	0.0644220681629339
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.00065189	0.0644220681629339
CULLER-JONES SYNDROME; CJS	0.00065189	0.0644220681629339
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.00065189	0.0644220681629339
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.00065189	0.0644220681629339
SECKEL SYNDROME 8; SCKL8	0.00065189	0.0644220681629339
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.00065189	0.0644220681629339
DESBUQUOIS DYSPLASIA 2; DBQD2	0.00065189	0.0644220681629339
SPASTIC PARAPLEGIA 63, AUTOSOMAL RECESSIVE; SPG63	0.00065189	0.0644220681629339
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.00065189	0.0644220681629339
BARAITSER-WINTER SYNDROME 2; BRWS2	0.00065189	0.0644220681629339
LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM	0.00065189	0.0644220681629339
HADZISELIMOVIC SYNDROME	0.00065189	0.0644220681629339
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.00065189	0.0644220681629339
SPONDYLOCOSTAL DYSOSTOSIS 4, AUTOSOMAL RECESSIVE; SCDO4	0.00065189	0.0644220681629339
CHROMOSOME 2Q31.1 DUPLICATION SYNDROME	0.00065189	0.0644220681629339
%613678 BRACHYOLMIA TYPE 2;;BRACHYOLMIA, MAROTEAUX TYPE	0.00065189	0.0644220681629339
SECKEL SYNDROME 4	0.00065189	0.0644220681629339
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.00065189	0.0644220681629339
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.00065189	0.0644220681629339
FORSYTHE-WAKELING SYNDROME; FWS	0.00065189	0.0644220681629339
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.00065189	0.0644220681629339
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.00065189	0.0644220681629339
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.00065189	0.0644220681629339
FANCONI ANEMIA, COMPLEMENTATION GROUP O	0.00065189	0.0644220681629339
BRACHYDACTYLY, TYPE E2; BDE2	0.00065189	0.0644220681629339
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.00065189	0.0644220681629339
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE, 2; ARHR2	0.00065189	0.0644220681629339
DIAMOND-BLACKFAN ANEMIA 10	0.00065189	0.0644220681629339
NOONAN SYNDROME 6; NS6	0.00065189	0.0644220681629339
WEILL-MARCHESANI SYNDROME 4; WMS4	0.00065189	0.0644220681629339
MACS SYNDROME	0.00065189	0.0644220681629339
PITUITARY HORMONE DEFICIENCY, COMBINED, 1	0.00065189	0.0644220681629339
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.00065189	0.0644220681629339
613005 SANTOS SYNDROME;;FIBULAR AGENESIS/HYPOPLASIA, OLIGODACTYLOUS CLUBFEET, AND ANONYCHIA/NAILHYPOPLASIA SYNDROME	0.00065189	0.0644220681629339
NOONAN SYNDROME 7; NS7	0.00065189	0.0644220681629339
WERNER SYNDROME; WRN	0.00065189	0.0644220681629339
CRANIOECTODERMAL DYSPLASIA 4	0.00065189	0.0644220681629339
SHORT-RIB THORACIC DYSPLASIA 4 WITH OR WITHOUT POLYDACTYLY; SRTD4	0.00065189	0.0644220681629339
FEINGOLD SYNDROME 2; FGLDS2	0.00065189	0.0644220681629339
CHROMOSOME 15Q25 DELETION SYNDROME	0.00065189	0.0644220681629339
STICKLER SYNDROME, TYPE V; STL5	0.00065189	0.0644220681629339
OROFACIODIGITAL SYNDROME VI	0.00065189	0.0644220681629339
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.00065189	0.0644220681629339
PERRAULT SYNDROME 3	0.00065189	0.0644220681629339
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.00065189	0.0644220681629339
CRANIOECTODERMAL DYSPLASIA 3	0.00065189	0.0644220681629339
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.00065189	0.0644220681629339
CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE	0.00065189	0.0644220681629339
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.00065189	0.0644220681629339
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.00065189	0.0644220681629339
N-ACETYLASPARTATE DEFICIENCY; NACED	0.00065189	0.0644220681629339
LISSENCEPHALY 4	0.00065189	0.0644220681629339
NESTOR-GUILLERMO PROGERIA SYNDROME; NGPS	0.00065189	0.0644220681629339
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.00065189	0.0644220681629339
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.00065189	0.0644220681629339
FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	0.00065189	0.0644220681629339
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.00065189	0.0644220681629339
OSTEOGENESIS IMPERFECTA, TYPE X	0.00065189	0.0644220681629339
SECKEL SYNDROME 5; SCKL5	0.00065189	0.0644220681629339
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.00065189	0.0644220681629339
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.00065189	0.0644220681629339
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.00065189	0.0644220681629339
ROTHMUND-THOMSON SYNDROME	0.00065189	0.0644220681629339
DYSTONIA 28, CHILDHOOD-ONSET	0.00065189	0.0644220681629339
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.00065189	0.0644220681629339
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.00065189	0.0644220681629339
FANCONI ANEMIA, COMPLEMENTATION GROUP V	0.00065189	0.0644220681629339
CHITAYAT SYNDROME	0.00065189	0.0644220681629339
SIFRIM-HITZ-WEISS SYNDROME	0.00065189	0.0644220681629339
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.00065189	0.0644220681629339
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.00065189	0.0644220681629339
ZTTK SYNDROME; ZTTKS	0.00065189	0.0644220681629339
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.00065189	0.0644220681629339
ALAZAMI-YUAN SYNDROME	0.00065189	0.0644220681629339
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.00065189	0.0644220681629339
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.00065189	0.0644220681629339
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.00065189	0.0644220681629339
MEIER-GORLIN SYNDROME 7	0.00065189	0.0644220681629339
HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 4; HNFJ4	0.00065189	0.0644220681629339
MIRAGE SYNDROME; MIRAGE	0.00065189	0.0644220681629339
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.00065189	0.0644220681629339
SACCHAROPINURIA	0.00065189	0.0644220681629339
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.00065189	0.0644220681629339
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.00065189	0.0644220681629339
OPTIC ATROPHY 11; OPA11	0.00065189	0.0644220681629339
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.00065189	0.0644220681629339
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.00065189	0.0644220681629339
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.00065189	0.0644220681629339
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.00065189	0.0644220681629339
AL KAISSI SYNDROME; ALKAS	0.00065189	0.0644220681629339
OVARIAN DYSGENESIS 5; ODG5	0.00065189	0.0644220681629339
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.00065189	0.0644220681629339
JOINT LAXITY, SHORT STATURE, AND MYOPIA; JLSM	0.00065189	0.0644220681629339
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.00065189	0.0644220681629339
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.00065189	0.0644220681629339
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.00065189	0.0644220681629339
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.00065189	0.0644220681629339
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.00065189	0.0644220681629339
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.00065189	0.0644220681629339
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.00065189	0.0644220681629339
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.00065189	0.0644220681629339
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.00065189	0.0644220681629339
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.00065189	0.0644220681629339
RODRIGUES BLINDNESS	0.00065189	0.0644220681629339
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00065189	0.0644220681629339
SHORT-RIB THORACIC DYSPLASIA 17 WITH OR WITHOUT POLYDACTYLY; SRTD17	0.00065189	0.0644220681629339
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.00065189	0.0644220681629339
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.00065189	0.0644220681629339
ANAUXETIC DYSPLASIA 2; ANXD2	0.00065189	0.0644220681629339
COFFIN-SIRIS SYNDROME 5	0.00065189	0.0644220681629339
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.00065189	0.0644220681629339
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.00065189	0.0644220681629339
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.00065189	0.0644220681629339
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.00065189	0.0644220681629339
FANCONI ANEMIA, COMPLEMENTATION GROUP T; FANCT	0.00065189	0.0644220681629339
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.00065189	0.0644220681629339
TRICHOTHIODYSTROPHY 2, PHOTOSENSITIVE	0.00065189	0.0644220681629339
CHOPS SYNDROME; CHOPS	0.00065189	0.0644220681629339
WHITE-SUTTON SYNDROME; WHSUS	0.00065189	0.0644220681629339
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.00065189	0.0644220681629339
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.00065189	0.0644220681629339
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.00065189	0.0644220681629339
SINGLETON-MERTEN SYNDROME 2; SGMRT2	0.00065189	0.0644220681629339
COLE-CARPENTER SYNDROME 2; CLCRP2	0.00065189	0.0644220681629339
LICHTENSTEIN-KNORR SYNDROME; LIKNS	0.00065189	0.0644220681629339
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.00065189	0.0644220681629339
SONODA SYNDROME	0.00065189	0.0644220681629339
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.00065189	0.0644220681629339
TEMPLE SYNDROME	0.00065189	0.0644220681629339
MYOPATHY, ISOLATED MITOCHONDRIAL, AUTOSOMAL DOMINANT; IMMD	0.00065189	0.0644220681629339
CEREBELLOFACIODENTAL SYNDROME	0.00065189	0.0644220681629339
RUIJS-AALFS SYNDROME; RJALS	0.00065189	0.0644220681629339
ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS; ACPHD	0.00065189	0.0644220681629339
OVARIAN DYSGENESIS 4; ODG4	0.00065189	0.0644220681629339
ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN	0.00065189	0.0644220681629339
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.00065189	0.0644220681629339
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.00065189	0.0644220681629339
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.00065189	0.0644220681629339
LYMPHEDEMA, HEREDITARY, III	0.00065189	0.0644220681629339
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.00065189	0.0644220681629339
LUSCAN-LUMISH SYNDROME; LLS	0.00065189	0.0644220681629339
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.00065189	0.0644220681629339
JOUBERT SYNDROME 26	0.00065189	0.0644220681629339
CRANIOMETADIAPHYSEAL DYSPLASIA; CRMDD	0.00065189	0.0644220681629339
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.00065189	0.0644220681629339
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.00065189	0.0644220681629339
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.00065189	0.0644220681629339
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.00065189	0.0644220681629339
OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17	0.00065189	0.0644220681629339
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.00065189	0.0644220681629339
ROIFMAN SYNDROME; RFMN	0.00065189	0.0644220681629339
269870 SHORT STATURE-OBESITY SYNDROME; SSOS	0.00065189	0.0644220681629339
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.00065189	0.0644220681629339
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.00065189	0.0644220681629339
NOONAN SYNDROME 10; NS10	0.00065189	0.0644220681629339
NOONAN SYNDROME 9; NS9	0.00065189	0.0644220681629339
SJOGREN-LARSSON SYNDROME; SLS	0.00065189	0.0644220681629339
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.00065189	0.0644220681629339
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.00065189	0.0644220681629339
THREE M SYNDROME 2; 3M2	0.00065189	0.0644220681629339
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.00065189	0.0644220681629339
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.00065189	0.0644220681629339
GRACILE BONE DYSPLASIA; GCLEB	0.00065189	0.0644220681629339
PIERPONT SYNDROME	0.00065189	0.0644220681629339
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.00065189	0.0644220681629339
RHYNS SYNDROME; RHYNS	0.00065189	0.0644220681629339
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.00065189	0.0644220681629339
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.00065189	0.0644220681629339
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 2	0.00065189	0.0644220681629339
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.00065189	0.0644220681629339
FABRY DISEASE	0.00065189	0.0644220681629339
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.00065189	0.0644220681629339
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.00065189	0.0644220681629339
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.00065189	0.0644220681629339
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.00065189	0.0644220681629339
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.00065189	0.0644220681629339
DYSSEGMENTAL DYSPLASIA WITH GLAUCOMA	0.00065189	0.0644220681629339
CHARGE-LIKE SYNDROME, X-LINKED	0.00065189	0.0644220681629339
STUVE-WIEDEMANN SYNDROME	0.00065189	0.0644220681629339
MUCOPOLYSACCHARIDOSIS TYPE IX	0.00065189	0.0644220681629339
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.00065189	0.0644220681629339
MASA SYNDROME	0.00065189	0.0644220681629339
HUNTER-MCALPINE CRANIOSYNOSTOSIS SYNDROME	0.00065189	0.0644220681629339
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.00065189	0.0644220681629339
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.00065189	0.0644220681629339
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.00065189	0.0644220681629339
RIGID SPINE MUSCULAR DYSTROPHY 1	0.00065189	0.0644220681629339
HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	0.00065189	0.0644220681629339
PROPIONIC ACIDEMIA	0.00065189	0.0644220681629339
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.00065189	0.0644220681629339
SPONDYLOOCULAR SYNDROME; SOS	0.00065189	0.0644220681629339
FANCONI ANEMIA, COMPLEMENTATION GROUP D1	0.00065189	0.0644220681629339
TONNE-KALSCHEUER SYNDROME; TOKAS	0.00065189	0.0644220681629339
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.00065189	0.0644220681629339
NOONAN SYNDROME 2; NS2	0.00065189	0.0644220681629339
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.00065189	0.0644220681629339
WIEDEMANN-STEINER SYNDROME; WDSTS	0.00065189	0.0644220681629339
XQ25 DUPLICATION SYNDROME	0.00065189	0.0644220681629339
MICROHYDRANENCEPHALY; MHAC	0.00065189	0.0644220681629339
CORTICAL DEFECTS, WORMIAN BONES, AND DENTINOGENESIS IMPERFECTA	0.00065189	0.0644220681629339
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.00065189	0.0644220681629339
GROWTH HORMONE INSENSITIVITY, PARTIAL; GHIP	0.00065189	0.0644220681629339
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.00065189	0.0644220681629339
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 2	0.00065189	0.0644220681629339
603463 HYPOSPADIAS, HYPERTELORISM, UPPER LID COLOBOMA, AND MIXED-TYPE HEARINGLOSS	0.00065189	0.0644220681629339
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.00065189	0.0644220681629339
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.00065189	0.0644220681629339
HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	0.00065189	0.0644220681629339
COFFIN-LOWRY SYNDROME; CLS	0.00065189	0.0644220681629339
CRANIOFRONTONASAL SYNDROME; CFNS	0.00065189	0.0644220681629339
BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES; BCYM4	0.00065189	0.0644220681629339
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.00065189	0.0644220681629339
INCONTINENTIA PIGMENTI; IP	0.00065189	0.0644220681629339
CODAS SYNDROME	0.00065189	0.0644220681629339
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.00065189	0.0644220681629339
PROTEINURIA, LOW MOLECULAR WEIGHT, WITH HYPERCALCIURIA AND NEPHROCALCINOSIS	0.00065189	0.0644220681629339
LOWE OCULOCEREBRORENAL SYNDROME	0.00065189	0.0644220681629339
WARBURG MICRO SYNDROME 1	0.00065189	0.0644220681629339
EIKEN SYNDROME	0.00065189	0.0644220681629339
MENKES DISEASE	0.00065189	0.0644220681629339
KEARNS-SAYRE SYNDROME; KSS	0.00065189	0.0644220681629339
RENPENNING SYNDROME 1; RENS1	0.00065189	0.0644220681629339
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.00065189	0.0644220681629339
WIEACKER-WOLFF SYNDROME	0.00065189	0.0644220681629339
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.00065189	0.0644220681629339
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.00065189	0.0644220681629339
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.00065189	0.0644220681629339
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.00065189	0.0644220681629339
SPASTIC PARAPARESIS AND DEAFNESS	0.00065189	0.0644220681629339
RETT SYNDROME; RTT	0.00065189	0.0644220681629339
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.00065189	0.0644220681629339
PELIZAEUS-MERZBACHER DISEASE	0.00065189	0.0644220681629339
%309620 MENTAL RETARDATION, SKELETAL DYSPLASIA, AND ABDUCENS PALSY; MRSD;;CHRISTIAN SYNDROME; CHRS	0.00065189	0.0644220681629339
%600384 APHALANGIA, PARTIAL, WITH SYNDACTYLY AND DUPLICATION OF METATARSALIV	0.00065189	0.0644220681629339
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.00065189	0.0644220681629339
SHORT STATURE SYNDROME, BRUSSELS TYPE	0.00065189	0.0644220681629339
CHROMOSOME 2Q37 DELETION SYNDROME	0.00065189	0.0644220681629339
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.00065189	0.0644220681629339
ECTODERMAL DYSPLASIA WITH NATAL TEETH, TURNPENNY TYPE	0.00065189	0.0644220681629339
SPINAL DYSPLASIA, ANHALT TYPE	0.00065189	0.0644220681629339
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.00065189	0.0644220681629339
DENTAL ANOMALIES AND SHORT STATURE; DASS	0.00065189	0.0644220681629339
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.00065189	0.0644220681629339
GURRIERI SYNDROME	0.00065189	0.0644220681629339
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.00065189	0.0644220681629339
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.00065189	0.0644220681629339
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.00065189	0.0644220681629339
AYME-GRIPP SYNDROME; AYGRP	0.00065189	0.0644220681629339
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.00065189	0.0644220681629339
MULLERIAN DUCT APLASIA, UNILATERAL RENAL AGENESIS, AND CERVICOTHORACICSOMITE ANOMALIES	0.00065189	0.0644220681629339
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.00065189	0.0644220681629339
FOCAL DERMAL HYPOPLASIA; FDH	0.00065189	0.0644220681629339
KENNERKNECHT SYNDROME	0.00065189	0.0644220681629339
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.00065189	0.0644220681629339
600736 VELOFACIOSKELETAL SYNDROME	0.00065189	0.0644220681629339
SATOYOSHI SYNDROME	0.00065189	0.0644220681629339
SPONDYLOEPIPHYSEAL DYSPLASIA WITH ATLANTOAXIAL INSTABILITY	0.00065189	0.0644220681629339
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.00065189	0.0644220681629339
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.00065189	0.0644220681629339
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.00065189	0.0644220681629339
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.00065189	0.0644220681629339
NOONAN SYNDROME 5; NS5	0.00065189	0.0644220681629339
ATKIN-FLAITZ SYNDROME	0.00065189	0.0644220681629339
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.00065189	0.0644220681629339
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.00065189	0.0644220681629339
OSTEOGENESIS IMPERFECTA, TYPE XI; OI11	0.00065189	0.0644220681629339
OSTEOGENESIS IMPERFECTA, TYPE V	0.00065189	0.0644220681629339
POTOCKI-LUPSKI SYNDROME	0.00065189	0.0644220681629339
IMMUNODEFICIENCY DUE TO DEFECT IN MAPBP-INTERACTING PROTEIN	0.00065189	0.0644220681629339
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.00065189	0.0644220681629339
CORNELIA DE LANGE SYNDROME 3	0.00065189	0.0644220681629339
NOONAN SYNDROME 4; NS4	0.00065189	0.0644220681629339
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.00065189	0.0644220681629339
OROFACIODIGITAL SYNDROME VIII; OFD8	0.00065189	0.0644220681629339
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.00065189	0.0644220681629339
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.00065189	0.0644220681629339
KOOLEN-DE VRIES SYNDROME; KDVS	0.00065189	0.0644220681629339
MEVALONIC ACIDURIA; MEVA	0.00065189	0.0644220681629339
MENTAL RETARDATION, X-LINKED 45	0.00065189	0.0644220681629339
MENTAL RETARDATION, X-LINKED 84	0.00065189	0.0644220681629339
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.00065189	0.0644220681629339
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.00065189	0.0644220681629339
NOONAN SYNDROME 3; NS3	0.00065189	0.0644220681629339
MENTAL RETARDATION, X-LINKED 2	0.00065189	0.0644220681629339
RENAL TUBULAR ACIDOSIS, DISTAL, WITH HEMOLYTIC ANEMIA	0.00065189	0.0644220681629339
MEND SYNDROME; MEND	0.00065189	0.0644220681629339
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.00065189	0.0644220681629339
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.00065189	0.0644220681629339
DENT DISEASE 1	0.00065189	0.0644220681629339
DIAMOND-BLACKFAN ANEMIA 8	0.00065189	0.0644220681629339
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.00065189	0.0644220681629339
DIAMOND-BLACKFAN ANEMIA 5	0.00065189	0.0644220681629339
DIAMOND-BLACKFAN ANEMIA 4	0.00065189	0.0644220681629339
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 3; CGL3	0.00065189	0.0644220681629339
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.00065189	0.0644220681629339
SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION	0.00065189	0.0644220681629339
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.00065189	0.0644220681629339
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.00065189	0.0644220681629339
GLASS SYNDROME	0.00065189	0.0644220681629339
FONTAINE PROGEROID SYNDROME; FPS	0.00065189	0.0644220681629339
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.00065189	0.0644220681629339
HYPOPHOSPHATEMIC RICKETS AND HYPERPARATHYROIDISM	0.00065189	0.0644220681629339
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.00065189	0.0644220681629339
HUNTER-MACDONALD SYNDROME	0.00065189	0.0644220681629339
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.00065189	0.0644220681629339
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.00065189	0.0644220681629339
LESCH-NYHAN SYNDROME; LNS	0.00065189	0.0644220681629339
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.00065189	0.0644220681629339
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.00065189	0.0644220681629339
SPONDYLOCOSTAL DYSOSTOSIS 3, AUTOSOMAL RECESSIVE; SCDO3	0.00065189	0.0644220681629339
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.00065189	0.0644220681629339
THYROID HORMONE METABOLISM, ABNORMAL; THMA	0.00065189	0.0644220681629339
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.00065189	0.0644220681629339
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00065189	0.0644220681629339
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.00065189	0.0644220681629339
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.00065189	0.0644220681629339
608028 THAI SYMPHALANGISM SYNDROME	0.00065189	0.0644220681629339
SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION; SPENCDI	0.00065189	0.0644220681629339
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00065189	0.0644220681629339
MENTAL RETARDATION, X-LINKED 92	0.00065189	0.0644220681629339
OGDEN SYNDROME; OGDNS	0.00065189	0.0644220681629339
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.00065189	0.0644220681629339
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.00065189	0.0644220681629339
NIEMANN-PICK DISEASE, TYPE B	0.00065189	0.0644220681629339
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.00065189	0.0644220681629339
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.00065189	0.0644220681629339
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.00065189	0.0644220681629339
MENTAL RETARDATION, X-LINKED 99	0.00065189	0.0644220681629339
TRICHOTHIODYSTROPHY 5, NONPHOTOSENSITIVE	0.00065189	0.0644220681629339
MENTAL RETARDATION, X-LINKED 12; MRX12	0.00065189	0.0644220681629339
HURLER-SCHEIE SYNDROME	0.00065189	0.0644220681629339
HURLER SYNDROME	0.00065189	0.0644220681629339
%607004 BRACHYDACTYLY, TYPE A1, B; BDA1B	0.00065189	0.0644220681629339
%300712 CRANIOFACIOSKELETAL SYNDROME	0.00065189	0.0644220681629339
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.00065189	0.0644220681629339
LARSEN-LIKE SYNDROME	0.00065189	0.0644220681629339
BRUCK SYNDROME 2	0.00065189	0.0644220681629339
HYPOPHOSPHATEMIC RICKETS, X-LINKED RECESSIVE	0.00065189	0.0644220681629339
FRIAS SYNDROME	0.00065189	0.0644220681629339
CHROMOSOME XP11.3 DELETION SYNDROME	0.00065189	0.0644220681629339
CHROMOSOME 10Q26 DELETION SYNDROME	0.00065189	0.0644220681629339
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION, X-LINKED; CFTDX	0.00065189	0.0644220681629339
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.00065189	0.0644220681629339
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH MINIEPIPHYSES	0.00065189	0.0644220681629339
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH SEVERE PROXIMAL FEMORAL DYSPLASIA	0.00065189	0.0644220681629339
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.00065189	0.0644220681629339
%609166 BRANCHIOGENIC-DEAFNESS SYNDROME	0.00065189	0.0644220681629339
ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY	0.00065189	0.0644220681629339
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.00065189	0.0644220681629339
CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION	0.00065189	0.0644220681629339
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.00065189	0.0644220681629339
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.00065189	0.0644220681629339
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.00065189	0.0644220681629339
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.00065189	0.0644220681629339
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.00065189	0.0644220681629339
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.00065189	0.0644220681629339
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.00065189	0.0644220681629339
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.00065189	0.0644220681629339
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.00065189	0.0644220681629339
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.00065189	0.0644220681629339
FACIAL DYSMORPHISM-ANOREXIA-CACHEXIA-EYE AND SKIN ANOMALIES SYNDROME	0.00065189	0.0644220681629339
EPILEPSY-TELANGIECTASIA SYNDROME	0.00065189	0.0644220681629339
CAT-EYE SYNDROME	0.00065189	0.0644220681629339
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.00065189	0.0644220681629339
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.00065189	0.0644220681629339
ENG-STROM SYNDROME	0.00065189	0.0644220681629339
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.00065189	0.0644220681629339
COHEN SYNDROME	0.00065189	0.0644220681629339
TOLUENE EMBRYOPATHY	0.00065189	0.0644220681629339
COFFIN-LOWRY SYNDROME	0.00065189	0.0644220681629339
FETAL METHYLMERCURY SYNDROME	0.00065189	0.0644220681629339
MARINESCO-SJOGREN SYNDROME; MSS	0.00065189	0.0644220681629339
FETAL HYDANTOIN SYNDROME	0.00065189	0.0644220681629339
COCKAYNE SYNDROME	0.00065189	0.0644220681629339
AMINOPTERIN/METHOTREXATE EMBRYOFETOPATHY	0.00065189	0.0644220681629339
EEC SYNDROME	0.00065189	0.0644220681629339
PRIMARY PIGMENTED NODULAR ADRENOCORTICAL DISEASE	0.00065189	0.0644220681629339
HIDROTIC ECTODERMAL DYSPLASIA	0.00065189	0.0644220681629339
ECTODERMAL DYSPLASIA-SENSORINEURAL DEAFNESS SYNDROME	0.00065189	0.0644220681629339
HYPOHIDROTIC ECTODERMAL DYSPLASIA-HYPOTHYROIDISM-CILIARY DYSKINESIA SYNDROME	0.00065189	0.0644220681629339
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00065189	0.0644220681629339
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.00065189	0.0644220681629339
EXTRASYSTOLES-SHORT STATURE-HYPERPIGMENTATION-MICROCEPHALY SYNDROME	0.00065189	0.0644220681629339
AUTOSOMAL RECESSIVE FACIODIGITOGENITAL SYNDROME	0.00065189	0.0644220681629339
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.00065189	0.0644220681629339
FEMORAL-FACIAL SYNDROME	0.00065189	0.0644220681629339
GMS SYNDROME	0.00065189	0.0644220681629339
CUTIS LAXA	0.00065189	0.0644220681629339
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.00065189	0.0644220681629339
GLAUCOMA-ECTOPIA LENTIS-MICROSPHEROPHAKIA-STIFF JOINTS-SHORT STATURE SYNDROME	0.00065189	0.0644220681629339
GERMAN SYNDROME	0.00065189	0.0644220681629339
GEMIGNANI SYNDROME	0.00065189	0.0644220681629339
GAPO SYNDROME	0.00065189	0.0644220681629339
MACROEPIPHYSEAL DYSPLASIA WITH OSTEOPOROSIS, WRINKLED SKIN, AND AGED APPEARANCE	0.00065189	0.0644220681629339
FRYNS-SMEETS-THIRY SYNDROME	0.00065189	0.0644220681629339
BLEPHAROPHIMOSIS-PTOSIS-ESOTROPIA-SYNDACTYLY-SHORT STATURE SYNDROME	0.00065189	0.0644220681629339
FREEMAN-SHELDON SYNDROME	0.00065189	0.0644220681629339
COLE-CARPENTER SYNDROME	0.00065189	0.0644220681629339
FLOATING-HARBOR SYNDROME	0.00065189	0.0644220681629339
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.00065189	0.0644220681629339
FIBROCHONDROGENESIS	0.00065189	0.0644220681629339
CONGENITAL FIBER-TYPE DISPROPORTION MYOPATHY	0.00065189	0.0644220681629339
FEMUR-FIBULA-ULNA COMPLEX	0.00065189	0.0644220681629339
CLEFT PALATE-SHORT STATURE-VERTEBRAL ANOMALIES SYNDROME	0.00065189	0.0644220681629339
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.00065189	0.0644220681629339
COWDEN SYNDROME	0.00065189	0.0644220681629339
CORNELIA DE LANGE SYNDROME	0.00065189	0.0644220681629339
MCDONOUGH SYNDROME	0.00065189	0.0644220681629339
SPONDYLOPERIPHERAL DYSPLASIA-SHORT ULNA SYNDROME	0.00065189	0.0644220681629339
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.00065189	0.0644220681629339
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.00065189	0.0644220681629339
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00065189	0.0644220681629339
MICROCEPHALY WITH CERVICAL SPINE FUSION ANOMALIES	0.00065189	0.0644220681629339
DISTAL TRISOMY 6P	0.00065189	0.0644220681629339
TRISOMY 5P	0.00065189	0.0644220681629339
NIJMEGEN BREAKAGE SYNDROME	0.00065189	0.0644220681629339
TRISOMY 4P	0.00065189	0.0644220681629339
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.00065189	0.0644220681629339
PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS	0.00065189	0.0644220681629339
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.00065189	0.0644220681629339
6Q16 MICRODELETION SYNDROME	0.00065189	0.0644220681629339
TRISOMY 18P	0.00065189	0.0644220681629339
17P11.2 MICRODUPLICATION SYNDROME	0.00065189	0.0644220681629339
DISTAL TRISOMY 14Q	0.00065189	0.0644220681629339
TRISOMY 12P	0.00065189	0.0644220681629339
NON-DISTAL TRISOMY 10Q	0.00065189	0.0644220681629339
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.00065189	0.0644220681629339
NATIVE AMERICAN MYOPATHY	0.00065189	0.0644220681629339
H SYNDROME	0.00065189	0.0644220681629339
WOLCOTT-RALLISON SYNDROME	0.00065189	0.0644220681629339
WORMIAN BONE-MULTIPLE FRACTURES-DENTINOGENESIS IMPERFECTA-SKELETAL DYSPLASIA	0.00065189	0.0644220681629339
ODONTOCHONDRODYSPLASIA	0.00065189	0.0644220681629339
TRISOMY XQ28	0.00065189	0.0644220681629339
DYSEQUILIBRIUM SYNDROME	0.00065189	0.0644220681629339
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.00065189	0.0644220681629339
XY TYPE GONADAL DYSGENESIS-ASSOCIATED ANOMALIES SYNDROME	0.00065189	0.0644220681629339
ULNA METAPHYSEAL DYSPLASIA SYNDROME	0.00065189	0.0644220681629339
MESOMELIC DYSPLASIA, KANTAPUTRA TYPE	0.00065189	0.0644220681629339
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.00065189	0.0644220681629339
OHDO SYNDROME	0.00065189	0.0644220681629339
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.00065189	0.0644220681629339
LOWRY-WOOD SYNDROME	0.00065189	0.0644220681629339
LEUKOMELANODERMA-INFANTILISM-INTELLECTUAL DISABILITY-HYPODONTIA-HYPOTRICHOSIS SYNDROME	0.00065189	0.0644220681629339
GROWTH HORMONE INSENSITIVITY SYNDROME	0.00065189	0.0644220681629339
MESOAXIAL HEXADACTYLY AND CARDIAC MALFORMATION	0.00065189	0.0644220681629339
ECTODERMAL DYSPLASIA-BLINDNESS SYNDROME	0.00065189	0.0644220681629339
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.00065189	0.0644220681629339
DYSOSTOSIS, STANESCU TYPE	0.00065189	0.0644220681629339
PERIPHERAL DYSOSTOSIS	0.00065189	0.0644220681629339
OCULOMAXILLOFACIAL DYSOSTOSIS	0.00065189	0.0644220681629339
FRONTOFACIONASAL DYSPLASIA	0.00065189	0.0644220681629339
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.00065189	0.0644220681629339
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00065189	0.0644220681629339
ACROFRONTOFACIONASAL DYSOSTOSIS	0.00065189	0.0644220681629339
DYSOSTEOSCLEROSIS	0.00065189	0.0644220681629339
DYSKERATOSIS CONGENITA	0.00065189	0.0644220681629339
45,X/46,XY MIXED GONADAL DYSGENESIS	0.00065189	0.0644220681629339
GORLIN-CHAUDHRY-MOSS SYNDROME	0.00065189	0.0644220681629339
GRANT SYNDROME	0.00065189	0.0644220681629339
LYMPHEDEMA-HYPOPARATHYROIDISM SYNDROME	0.00065189	0.0644220681629339
MESOMELIA-SYNOSTOSES SYNDROME	0.00065189	0.0644220681629339
MÜLLERIAN DUCT ANOMALIES-LIMB ANOMALIES SYNDROME	0.00065189	0.0644220681629339
MELNICK-NEEDLES SYNDROME	0.00065189	0.0644220681629339
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.00065189	0.0644220681629339
MÜLLERIAN APLASIA AND HYPERANDROGENISM	0.00065189	0.0644220681629339
HARTNUP DISORDER	0.00065189	0.0644220681629339
MOWAT-WILSON SYNDROME; MOWS	0.00065189	0.0644220681629339
MCKUSICK-KAUFMAN SYNDROME	0.00065189	0.0644220681629339
MCDONOUGH SYNDROME	0.00065189	0.0644220681629339
HOLOPROSENCEPHALY 1; HPE1	0.00065189	0.0644220681629339
MASA SYNDROME	0.00065189	0.0644220681629339
RFT1-CDG	0.00065189	0.0644220681629339
236450 HUTTERITE CEREBROOSTEONEPHRODYSPLASIA SYNDROME;;COND;;CEREBROOSTEONEPHOSIS SYNDROME	0.00065189	0.0644220681629339
HYPO- AND HYPERMELANOTIC CUTANEOUS MACULES-RETARDED GROWTH-INTELLECTUAL DISABILITY SYNDROME	0.00065189	0.0644220681629339
46,XX GONADAL DYSGENESIS	0.00065189	0.0644220681629339
HYPERGONADOTROPIC HYPOGONADISM-CATARACT SYNDROME	0.00065189	0.0644220681629339
DYSCHROMATOSIS UNIVERSALIS HEREDITARIA	0.00065189	0.0644220681629339
PAGET DISEASE OF BONE 5, JUVENILE-ONSET	0.00065189	0.0644220681629339
CHOREOACANTHOCYTOSIS	0.00065189	0.0644220681629339
1Q44 MICRODELETION SYNDROME	0.00065189	0.0644220681629339
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.00065189	0.0644220681629339
FAMILIAL CLUBFOOT DUE TO 17Q23.1Q23.2 MICRODUPLICATION	0.00065189	0.0644220681629339
FATCO SYNDROME	0.00065189	0.0644220681629339
233430 GONADAL DYSGENESIS, XY TYPE, WITH ASSOCIATED ANOMALIES	0.00065189	0.0644220681629339
245800 LAURENCE-MOON SYNDROME	0.00065189	0.0644220681629339
FRONTONASAL DYSPLASIA	0.00065189	0.0644220681629339
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.00065189	0.0644220681629339
AUTOSOMAL DOMINANT PRIMARY MICROCEPHALY	0.00065189	0.0644220681629339
ATAXIA-TELANGIECTASIA-LIKE DISORDER	0.00065189	0.0644220681629339
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.00065189	0.0644220681629339
8P23.1 MICRODELETION SYNDROME	0.00065189	0.0644220681629339
8P11.2 DELETION SYNDROME	0.00065189	0.0644220681629339
6Q25 MICRODELETION SYNDROME	0.00065189	0.0644220681629339
2Q32Q33 MICRODELETION SYNDROME	0.00065189	0.0644220681629339
2Q31.1 MICRODELETION SYNDROME	0.00065189	0.0644220681629339
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.00065189	0.0644220681629339
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.00065189	0.0644220681629339
MICRO SYNDROME	0.00065189	0.0644220681629339
MULTIPLE EPIPHYSEAL DYSPLASIA	0.00065189	0.0644220681629339
1Q41Q42 MICRODELETION SYNDROME	0.00065189	0.0644220681629339
1Q21.1 MICRODELETION SYNDROME	0.00065189	0.0644220681629339
AUTOSOMAL RECESSIVE STICKLER SYNDROME	0.00065189	0.0644220681629339
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.00065189	0.0644220681629339
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.00065189	0.0644220681629339
GLYCOGEN STORAGE DISEASE IA	0.00065189	0.0644220681629339
GLYCOGEN STORAGE DISEASE IB	0.00065189	0.0644220681629339
ACROGERIA	0.00065189	0.0644220681629339
15Q11Q13 MICRODUPLICATION SYNDROME	0.00065189	0.0644220681629339
LEGG-CALVÉ-PERTHES DISEASE	0.00065189	0.0644220681629339
LAURENCE-MOON SYNDROME	0.00065189	0.0644220681629339
CONGENITAL LARYNGEAL WEB	0.00065189	0.0644220681629339
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.00065189	0.0644220681629339
HYPOGONADOTROPIC HYPOGONADISM-RETINITIS PIGMENTOSA SYNDROME	0.00065189	0.0644220681629339
MALE HYPERGONADOTROPIC HYPOGONADISM-INTELLECTUAL DISABILITY-SKELETAL ANOMALIES SYNDROME	0.00065189	0.0644220681629339
HYPOGONADISM-MITRAL VALVE PROLAPSE-INTELLECTUAL DISABILITY SYNDROME	0.00065189	0.0644220681629339
NEPHROGENIC DIABETES INSIPIDUS	0.00065189	0.0644220681629339
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.00065189	0.0644220681629339
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.00065189	0.0644220681629339
PSEUDOAMINOPTERIN SYNDROME	0.00065189	0.0644220681629339
ROTHMUND-THOMSON SYNDROME TYPE 1	0.00065189	0.0644220681629339
OROFACIODIGITAL SYNDROME I; OFD1	0.00065189	0.0644220681629339
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.00065189	0.0644220681629339
HYDROCEPHALUS-OBESITY-HYPOGONADISM SYNDROME	0.00065189	0.0644220681629339
BARAITSER-WINTER SYNDROME 1; BRWS1	0.00065189	0.0644220681629339
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.00065189	0.0644220681629339
MOWAT-WILSON SYNDROME	0.00065189	0.0644220681629339
CRANIOSYNOSTOSIS, HERRMANN-OPITZ TYPE	0.00065189	0.0644220681629339
JOHANSON-BLIZZARD SYNDROME; JBS	0.00065189	0.0644220681629339
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.00065189	0.0644220681629339
CYSTINOSIS	0.00065189	0.0644220681629339
245160 KNIEST-LIKE DYSPLASIA WITH PURSED LIPS AND ECTOPIA LENTIS;;BURTON SYNDROME	0.00065189	0.0644220681629339
HALL-RIGGS SYNDROME	0.00065189	0.0644220681629339
PERMANENT CONGENITAL HYPOTHYROIDISM	0.00065189	0.0644220681629339
PRIMARY CONGENITAL HYPOTHYROIDISM	0.00065189	0.0644220681629339
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.00065189	0.0644220681629339
JOHANSON-BLIZZARD SYNDROME	0.00065189	0.0644220681629339
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.00065189	0.0644220681629339
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.00065189	0.0644220681629339
MUSCULAR PSEUDOHYPERTROPHY-HYPOTHYROIDISM SYNDROME	0.00065189	0.0644220681629339
HYPOPHOSPHATASIA, CHILDHOOD	0.00065189	0.0644220681629339
KBG SYNDROME	0.00065189	0.0644220681629339
KALLMANN SYNDROME-HEART DISEASE SYNDROME	0.00065189	0.0644220681629339
SANJAD-SAKATI SYNDROME	0.00065189	0.0644220681629339
KABUKI SYNDROME	0.00065189	0.0644220681629339
NON-ACQUIRED COMBINED PITUITARY HORMONE DEFICIENCY-SENSORINEURAL HEARING LOSS-SPINE ABNORMALITIES SYNDROME	0.00065189	0.0644220681629339
ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	0.00065189	0.0644220681629339
ICF SYNDROME	0.00065189	0.0644220681629339
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.00065189	0.0644220681629339
JACOBSEN SYNDROME	0.00065189	0.0644220681629339
CONGENITAL SHORT BOWEL SYNDROME	0.00065189	0.0644220681629339
ARGININOSUCCINIC ACIDURIA	0.00065189	0.0644220681629339
ISOLATED AGAMMAGLOBULINEMIA	0.00065189	0.0644220681629339
5Q35 MICRODUPLICATION SYNDROME	0.00065189	0.0644220681629339
POLYVALVULAR HEART DISEASE SYNDROME	0.00065189	0.0644220681629339
2Q23.1 MICRODELETION SYNDROME	0.00065189	0.0644220681629339
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00065189	0.0644220681629339
ISOLATED OSTEOPOIKILOSIS	0.00065189	0.0644220681629339
MULTIPLE EPIPHYSEAL DYSPLASIA DUE TO COLLAGEN 9 ANOMALY	0.00065189	0.0644220681629339
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.00065189	0.0644220681629339
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.00065189	0.0644220681629339
PORPHYRIA, CONGENITAL ERYTHROPOIETIC; CEP	0.00065189	0.0644220681629339
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.00065189	0.0644220681629339
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.00065189	0.0644220681629339
264010 PRADER-WILLI HABITUS, OSTEOPENIA, AND CAMPTODACTYLY;;URBAN-ROGERS-MEYER SYNDROME	0.00065189	0.0644220681629339
NOONAN SYNDROME 11; NS11	0.00065189	0.0644220681629339
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.00065189	0.0644220681629339
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.00065189	0.0644220681629339
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.00065189	0.0644220681629339
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.00065189	0.0644220681629339
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.00065189	0.0644220681629339
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.00065189	0.0644220681629339
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.00065189	0.0644220681629339
OCULOSKELETODENTAL SYNDROME; OCSKD	0.00065189	0.0644220681629339
ARTHROGRYPOSIS, DISTAL, TYPE 2B3; DA2B3	0.00065189	0.0644220681629339
POTOCKI-LUPSKI SYNDROME (17P11.2 DUPLICATION SYNDROME)	0.00065189	0.0644220681629339
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.00065189	0.0644220681629339
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 3; SEMDJL3	0.00065189	0.0644220681629339
SPONDYLOEPIPHYSEAL DYSPLASIA, KONDO-FU TYPE; SEDKF	0.00065189	0.0644220681629339
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.00065189	0.0644220681629339
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.00065189	0.0644220681629339
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.00065189	0.0644220681629339
ATAXIA-TELANGIECTASIA	0.00065189	0.0644220681629339
2Q37 MICRODELETION SYNDROME	0.00065189	0.0644220681629339
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.00065189	0.0644220681629339
ALOPECIA ANTIBODY DEFICIENCY	0.00065189	0.0644220681629339
PROGRESSIVE PSEUDORHEUMATOID ARTHROPATHY OF CHILDHOOD	0.00065189	0.0644220681629339
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.00065189	0.0644220681629339
SHELDON-HALL SYNDROME	0.00065189	0.0644220681629339
ARTHROGRYPOSIS-LIKE HAND ANOMALY-SENSORINEURAL DEAFNESS SYNDROME	0.00065189	0.0644220681629339
AURICULOOSTEODYSPLASIA	0.00065189	0.0644220681629339
AREDYLD SYNDROME	0.00065189	0.0644220681629339
X-LINKED MANDIBULOFACIAL DYSOSTOSIS	0.00065189	0.0644220681629339
CAUDAL APPENDAGE-DEAFNESS SYNDROME	0.00065189	0.0644220681629339
BARTTER SYNDROME	0.00065189	0.0644220681629339
APHALANGY-SYNDACTYLY-MICROCEPHALY SYNDROME	0.00065189	0.0644220681629339
MICROPHTHALMIA WITH LIMB ANOMALIES	0.00065189	0.0644220681629339
BARDET-BIEDL SYNDROME	0.00065189	0.0644220681629339
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.00065189	0.0644220681629339
ANIRIDIA-RENAL AGENESIS-PSYCHOMOTOR RETARDATION SYNDROME	0.00065189	0.0644220681629339
PFEIFFER-PALM-TELLER SYNDROME	0.00065189	0.0644220681629339
METAPHYSEAL ANADYSPLASIA	0.00065189	0.0644220681629339
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.00065189	0.0644220681629339
GLYCOGEN STORAGE DISEASE IXB	0.00065189	0.0644220681629339
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 23	0.00065189	0.0644220681629339
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.00065189	0.0644220681629339
FRAXE INTELLECTUAL DISABILITY	0.00065189	0.0644220681629339
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.00065189	0.0644220681629339
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.00065189	0.0644220681629339
XP22.3 MICRODELETION SYNDROME	0.00065189	0.0644220681629339
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.00065189	0.0644220681629339
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.00065189	0.0644220681629339
MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE; MCPH21	0.00065189	0.0644220681629339
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, DI ROCCO TYPE; SEMDDR	0.00065189	0.0644220681629339
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.00065189	0.0644220681629339
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.00065189	0.0644220681629339
SPINOCEREBELLAR ATAXIA 47; SCA47	0.00065189	0.0644220681629339
CHROMOSOME 1P35 DELETION SYNDROME	0.00065189	0.0644220681629339
OROFACIODIGITAL SYNDROME XVIII; OFD18	0.00065189	0.0644220681629339
OROFACIODIGITAL SYNDROME XVII	0.00065189	0.0644220681629339
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.00065189	0.0644220681629339
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.00065189	0.0644220681629339
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.00065189	0.0644220681629339
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.00065189	0.0644220681629339
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.00065189	0.0644220681629339
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.00065189	0.0644220681629339
IMMUNODEFICIENCY 55; IMD55	0.00065189	0.0644220681629339
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.00065189	0.0644220681629339
COFFIN-SIRIS SYNDROME 6; CSS6	0.00065189	0.0644220681629339
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00065189	0.0644220681629339
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.00065189	0.0644220681629339
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.00065189	0.0644220681629339
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.00065189	0.0644220681629339
COFFIN-SIRIS SYNDROME 7; CSS7	0.00065189	0.0644220681629339
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.00065189	0.0644220681629339
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.00065189	0.0644220681629339
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.00065189	0.0644220681629339
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.00065189	0.0644220681629339
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.00065189	0.0644220681629339
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.00065189	0.0644220681629339
ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ACCIID	0.00065189	0.0644220681629339
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.00065189	0.0644220681629339
NEPHROTIC SYNDROME, TYPE 17; NPHS17	0.00065189	0.0644220681629339
PYCNODYSOSTOSIS	0.00065189	0.0644220681629339
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.00065189	0.0644220681629339
PYGMY	0.00065189	0.0644220681629339
ISOLATED GROWTH HORMONE DEFICIENCY, TYPE V; IGHD5	0.00065189	0.0644220681629339
SAUL-WILSON SYNDROME; SWILS	0.00065189	0.0644220681629339
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.00065189	0.0644220681629339
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.00065189	0.0644220681629339
POLYDACTYLY, POSTAXIAL, TYPE A8; PAPA8	0.00065189	0.0644220681629339
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.00065189	0.0644220681629339
RAMON SYNDROME	0.00065189	0.0644220681629339
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.00065189	0.0644220681629339
RAPADILINO SYNDROME	0.00065189	0.0644220681629339
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.00065189	0.0644220681629339
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.00065189	0.0644220681629339
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.00065189	0.0644220681629339
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.00065189	0.0644220681629339
260150 PALANT CLEFT PALATE SYNDROME	0.00065189	0.0644220681629339
CRANIOFACIAL DYSSYNOSTOSIS	0.00065189	0.0644220681629339
CRANIODIAPHYSEAL DYSPLASIA	0.00065189	0.0644220681629339
COXOAURICULAR SYNDROME	0.00065189	0.0644220681629339
MYOSCLEROSIS, AUTOSOMAL RECESSIVE	0.00065189	0.0644220681629339
MYOTONIA WITH SKELETAL ABNORMALITIES AND MENTAL RETARDATION	0.00065189	0.0644220681629339
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.00065189	0.0644220681629339
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.00065189	0.0644220681629339
VICI SYNDROME	0.00065189	0.0644220681629339
COOPER-JABS SYNDROME	0.00065189	0.0644220681629339
LETHAL CONGENITAL CONTRACTURE SYNDROME TYPE 1	0.00065189	0.0644220681629339
COLOBOMA OF MACULA-BRACHYDACTYLY TYPE B SYNDROME	0.00065189	0.0644220681629339
NASODIGITOACOUSTIC SYNDROME	0.00065189	0.0644220681629339
COFFIN-SIRIS SYNDROME	0.00065189	0.0644220681629339
CODAS SYNDROME	0.00065189	0.0644220681629339
CLEIDOCRANIAL DYSPLASIA	0.00065189	0.0644220681629339
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.00065189	0.0644220681629339
RING CHROMOSOME 7 SYNDROME	0.00065189	0.0644220681629339
RING CHROMOSOME 6 SYNDROME	0.00065189	0.0644220681629339
X-LINKED SKELETAL DYSPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.00065189	0.0644220681629339
BIEMOND SYNDROME TYPE 2	0.00065189	0.0644220681629339
TARSAL-CARPAL COALITION SYNDROME	0.00065189	0.0644220681629339
NEURAMINIDASE DEFICIENCY	0.00065189	0.0644220681629339
CRANIODIGITAL-INTELLECTUAL DISABILITY SYNDROME	0.00065189	0.0644220681629339
GÓMEZ-LÓPEZ-HERNÁNDEZ SYNDROME	0.00065189	0.0644220681629339
CEREBELLAR ATAXIA-HYPOGONADISM SYNDROME	0.00065189	0.0644220681629339
FAMILIAL BENIGN COPPER DEFICIENCY	0.00065189	0.0644220681629339
X-LINKED INTELLECTUAL DISABILITY-CRANIOFACIOSKELETAL SYNDROME	0.00065189	0.0644220681629339
X-LINKED INTELLECTUAL DISABILITY, VAN ESCH TYPE	0.00065189	0.0644220681629339
X-LINKED INTELLECTUAL DISABILITY, CILLIERS TYPE	0.00065189	0.0644220681629339
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.00065189	0.0644220681629339
MAFFUCCI SYNDROME	0.00065189	0.0644220681629339
DISTAL MONOSOMY 3P	0.00065189	0.0644220681629339
1P36 DELETION SYNDROME	0.00065189	0.0644220681629339
MONOSOMY 18Q	0.00065189	0.0644220681629339
MONOSOMY 18P	0.00065189	0.0644220681629339
DISTAL MONOSOMY 17Q	0.00065189	0.0644220681629339
DISTAL MONOSOMY 15Q	0.00065189	0.0644220681629339
DISTAL MONOSOMY 13Q	0.00065189	0.0644220681629339
MONOSOMY 13Q14	0.00065189	0.0644220681629339
MUCOLIPIDOSIS III ALPHA/BETA	0.00065189	0.0644220681629339
DISTAL MONOSOMY 10P	0.00065189	0.0644220681629339
MUCOLIPIDOSIS III GAMMA	0.00065189	0.0644220681629339
ANE SYNDROME	0.00065189	0.0644220681629339
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.00065189	0.0644220681629339
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.00065189	0.0644220681629339
HEREDITARY HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA	0.00065189	0.0644220681629339
DAHLBERG-BORER-NEWCOMER SYNDROME	0.00065189	0.0644220681629339
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.00065189	0.0644220681629339
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.00065189	0.0644220681629339
NIEMANN-PICK DISEASE, TYPE A	0.00065189	0.0644220681629339
CAMPOMELIC DYSPLASIA	0.00065189	0.0644220681629339
BRANCHIO-OCULO-FACIAL SYNDROME	0.00065189	0.0644220681629339
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.00065189	0.0644220681629339
BRACHYDACTYLY-ARTERIAL HYPERTENSION SYNDROME	0.00065189	0.0644220681629339
AYMÉ-GRIPP SYNDROME	0.00065189	0.0644220681629339
BOWEN-CONRADI SYNDROME	0.00065189	0.0644220681629339
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.00065189	0.0644220681629339
259610 OSTEOLYSIS SYNDROME, RECESSIVE;;OSTEOLYSIS, DISTAL, WITH SHORT STATURE, MENTAL RETARDATION, AND CHARACTERISTICFACIAL APPEARANCE	0.00065189	0.0644220681629339
BONNEMANN-MEINECKE-REICH SYNDROME	0.00065189	0.0644220681629339
BLOOM SYNDROME	0.00065189	0.0644220681629339
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.00065189	0.0644220681629339
BALLER-GEROLD SYNDROME	0.00065189	0.0644220681629339
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3	0.00065189	0.0644220681629339
LARYNX ATRESIA	0.00065189	0.0644220681629339
ATRESIA OF SMALL INTESTINE	0.00065189	0.0644220681629339
CHOANAL ATRESIA-HEARING LOSS-CARDIAC DEFECTS-CRANIOFACIAL DYSMORPHISM SYNDROME	0.00065189	0.0644220681629339
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.00065189	0.0644220681629339
ATKIN-FLAITZ SYNDROME	0.00065189	0.0644220681629339
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.00065189	0.0644220681629339
RAINE SYNDROME	0.00065189	0.0644220681629339
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.00065189	0.0644220681629339
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.00065189	0.0644220681629339
FEINGOLD SYNDROME	0.00065189	0.0644220681629339
BUSCHKE-OLLENDORFF SYNDROME	0.00065189	0.0644220681629339
DISTAL LIMB DEFICIENCIES-MICROGNATHIA SYNDROME	0.00065189	0.0644220681629339
CATARACT-ABERRANT ORAL FRENULA-GROWTH DELAY SYNDROME	0.00065189	0.0644220681629339
17Q11.2 MICRODUPLICATION SYNDROME	0.00065189	0.0644220681629339
CEREBROFACIOTHORACIC DYSPLASIA	0.00065189	0.0644220681629339
CEREBROCOSTOMANDIBULAR SYNDROME	0.00065189	0.0644220681629339
CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-POLYDACTYLY SYNDROME	0.00065189	0.0644220681629339
CATEL-MANZKE SYNDROME	0.00065189	0.0644220681629339
CATARACT-INTELLECTUAL DISABILITY-HYPOGONADISM SYNDROME	0.00065189	0.0644220681629339
CATARACT-DEAFNESS-HYPOGONADISM SYNDROME	0.00065189	0.0644220681629339
CATARACT-NEPHROPATHY-ENCEPHALOPATHY SYNDROME	0.00065189	0.0644220681629339
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.00065189	0.0644220681629339
OCULOPALATOCEREBRAL SYNDROME	0.00065189	0.0644220681629339
PRIMROSE SYNDROME; PRIMS	0.00065189	0.0644220681629339
CATARACT-ATAXIA-DEAFNESS SYNDROME	0.00065189	0.0644220681629339
OROFACIODIGITAL SYNDROME IV; OFD4	0.00065189	0.0644220681629339
CAREY-FINEMAN-ZITER SYNDROME	0.00065189	0.0644220681629339
CONGENITAL HEART DEFECT-ROUND FACE-DEVELOPMENTAL DELAY SYNDROME	0.00065189	0.0644220681629339
OROFACIODIGITAL SYNDROME IX; OFD9	0.00065189	0.0644220681629339
CARDIOFACIOCUTANEOUS SYNDROME	0.00065189	0.0644220681629339
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.00065189	0.0644220681629339
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 2	0.00065189	0.0644220681629339
CAMPTODACTYLY-JOINT CONTRACTURES-FACIAL SKELETAL DEFECTS SYNDROME	0.00065189	0.0644220681629339
POPOV-CHANG SYNDROME; POPCHAS	0.00065189	0.0644220681629339
